{
  "meta": {
    "id": "test69",
    "title": "Mid Day Module (PSM-2) - 2025-02-13",
    "category": "Subject Wise / Mixed"
  },
  "questions": [
    {
      "text": "A research team is conducting a study to assess the well-being of individuals in a large urban community. They are collecting various data points to evaluate both the subjective and objective aspects of well-being. Which of the following data points would primarily assess a subjective component of well-being?",
      "options": [
        {
          "label": "A",
          "text": "Standard of living",
          "correct": false
        },
        {
          "label": "B",
          "text": "Level of Living",
          "correct": false
        },
        {
          "label": "C",
          "text": "Quality of life",
          "correct": true
        },
        {
          "label": "D",
          "text": "HDI",
          "correct": false
        }
      ],
      "correct_answer": "C. Quality of life",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Quality of life</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Standard of living : Objective Component. WHO includes Income & Occupation , Standards of housing , sanitation & nutrition , and level of provision of health , educational, recreational & other services, within this component. The standard of living depends on \u2018 Per capita GNP\u2019.</li><li>\u2022 Option A. Standard of living</li><li>\u2022 WHO</li><li>\u2022 Income & Occupation</li><li>\u2022 Standards of housing</li><li>\u2022 sanitation & nutrition</li><li>\u2022 level of provision of health</li><li>\u2022 Per capita GNP\u2019.</li><li>\u2022 Option B. Level of living :  An objective Component. The most important indicator to assess level of living is IMR .</li><li>\u2022 Option B. Level of living</li><li>\u2022 indicator to assess level of living</li><li>\u2022 IMR</li><li>\u2022 Option D. HDI : Human Development Index is a composite index comprising of 3 dimensions : Knowledge , Income and Longevity .</li><li>\u2022 Option D. HDI</li><li>\u2022 Human Development Index</li><li>\u2022 composite index</li><li>\u2022 3 dimensions</li><li>\u2022 Knowledge</li><li>\u2022 Income</li><li>\u2022 Longevity</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 WHO Concept of Well-being</li><li>\u27a4 Objective component : Standard of living, Level of living Subjective component : Quality of life</li><li>\u27a4 Objective component : Standard of living, Level of living</li><li>\u27a4 Objective component</li><li>\u27a4 Subjective component : Quality of life</li><li>\u27a4 Subjective component</li><li>\u27a4 Ref : Park 26th ed, pg 16.</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26th ed, pg 16.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "6dc12d95",
      "audio": ""
    },
    {
      "text": "A public health specialist is giving a presentation on different indices used to measure the quality of life in various countries. She explains that the Physical Quality of Life Index (PQLI) is one of the indices used and it includes specific parameters. Which of the following parameters is NOT traditionally included in the Physical Quality of Life Index?",
      "options": [
        {
          "label": "A",
          "text": "Infant mortality",
          "correct": false
        },
        {
          "label": "B",
          "text": "Life expectancy at age one",
          "correct": false
        },
        {
          "label": "C",
          "text": "Education",
          "correct": false
        },
        {
          "label": "D",
          "text": "Life expectancy at birth",
          "correct": true
        }
      ],
      "correct_answer": "D. Life expectancy at birth",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-165503.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Life expectancy at birth</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Ref : Park 26 th ed, pg 17.</li><li>\u27a4 Ref : Park 26 th ed, pg 17.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bc3f6a77",
      "audio": ""
    },
    {
      "text": "A statistician is analyzing data to understand the factors influencing the disability rate in a particular region. She is categorizing various indicators based on their types and their relation to disability. Which of the following would she most likely NOT categorize as an event type indicator of disability rate?",
      "options": [
        {
          "label": "A",
          "text": "\u200b\u200b\u200b\u200b Bed disability days",
          "correct": false
        },
        {
          "label": "B",
          "text": "Days of restricted activities",
          "correct": false
        },
        {
          "label": "C",
          "text": "Limitation of mobility",
          "correct": true
        },
        {
          "label": "D",
          "text": "Work loss days",
          "correct": false
        }
      ],
      "correct_answer": "C. Limitation of mobility",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/11/screenshot-2023-08-11-192002_vd2ujuS.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Limitation of mobility</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Other 3 options are Event type indicator , as mentioned in above table .</li><li>\u2022 3 options are Event type indicator</li><li>\u2022 above table</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Limitation of mobility is a person-type indicator , while bed disability , number of days of restricted activity and work loss days are the event-type indicators.</li><li>\u27a4 Limitation of mobility</li><li>\u27a4 person-type indicator</li><li>\u27a4 bed disability</li><li>\u27a4 Ref : Park 26 th ed, pg 26.</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26 th ed, pg 26.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "00305cde",
      "audio": ""
    },
    {
      "text": "A public health student is learning about different metrics used to assess the impact of diseases on populations. He comes across a measure that expresses the overall disease burden in terms of ill health, disability, or early death. What is this measure known as?",
      "options": [
        {
          "label": "A",
          "text": "Health adjusted life expectancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sullivan's index",
          "correct": false
        },
        {
          "label": "C",
          "text": "Disability free life expectancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Disability Adjusted life expectancy",
          "correct": true
        }
      ],
      "correct_answer": "D. Disability Adjusted life expectancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Disability Adjusted life expectancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A . HALE : Health-Adjusted Life Expectancy , and it represents the average number of years that a person can expect to live in \"full health\", factoring in years lived in less than full health due to disease and/or injury.</li><li>\u2022 Option A</li><li>\u2022 HALE</li><li>\u2022 Health-Adjusted Life Expectancy</li><li>\u2022 represents the average number of years</li><li>\u2022 person can expect to live</li><li>\u2022 \"full health\",</li><li>\u2022 Option B . Sullivan's index: Sullivan's index represents the expectation of life free from disability . It is a measure that combines both morbidity and mortality data to provide an estimate of the quality of life in terms of years lived without disability. It is one of the most advanced indicators currently available.</li><li>\u2022 Option B</li><li>\u2022 Sullivan's index:</li><li>\u2022 expectation of life free from disability</li><li>\u2022 measure that combines both morbidity</li><li>\u2022 mortality data</li><li>\u2022 estimate of the quality of life</li><li>\u2022 Sullivan\u2019s Index = Life Expectancy MINUS Duration of disability (bed disability and inability to perform major activities)</li><li>\u2022 Option C . DFLE : Disability-Free Life Expectancy , represents the average number of years an individual is expected to live free of disability .</li><li>\u2022 Option C</li><li>\u2022 DFLE</li><li>\u2022 Disability-Free Life Expectancy</li><li>\u2022 average number of years</li><li>\u2022 individual</li><li>\u2022 live free of disability</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Disability Adjusted Life Years [ DALYs ] - Is the BEST measure of burden of disease in a defined population and the effectiveness of interventions . DALYs can measure \u2018both mortality and disability together\u2019</li><li>\u27a4 Disability Adjusted Life Years</li><li>\u27a4 DALYs</li><li>\u27a4 BEST measure of burden of disease</li><li>\u27a4 population</li><li>\u27a4 effectiveness of interventions</li><li>\u27a4 Ref : Park 26 th ed, pg 26.</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26 th ed, pg 26.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "68a91d16",
      "audio": ""
    },
    {
      "text": "A microbiology student is studying the principles of pathogen identification and comes across Henle-Koch\u2019s postulates. These postulates were formulated to establish a causative relationship between a specific microorganism and a specific disease. Which of the following best describes the central philosophy of Henle-Koch's postulates?",
      "options": [
        {
          "label": "A",
          "text": "Miasma Theory",
          "correct": false
        },
        {
          "label": "B",
          "text": "Germ Theory",
          "correct": true
        },
        {
          "label": "C",
          "text": "Web of causation theory",
          "correct": false
        },
        {
          "label": "D",
          "text": "Epidemiological Wheel theory",
          "correct": false
        }
      ],
      "correct_answer": "B. Germ Theory",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Germ Theory</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Miasma Theory: Human diseases are due to bad air</li><li>\u2022 Option A. Miasma Theory:</li><li>\u2022 Human diseases</li><li>\u2022 bad air</li><li>\u2022 Option C. Web of causation theory : Various factors interact like web to cause disease.</li><li>\u2022 Option C. Web of causation theory</li><li>\u2022 Various factors</li><li>\u2022 web to cause disease.</li><li>\u2022 Option D. Epidemiological wheel theory: Visualizes human disease in form of wheel with central hub and spoke which are contributed by various factors.</li><li>\u2022 Option D. Epidemiological wheel theory:</li><li>\u2022 Visualizes human disease</li><li>\u2022 form of wheel</li><li>\u2022 central hub</li><li>\u2022 spoke</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Robert Koch was a distinguished German microbiologist; Koch's legacy lies in the germ theory . He is famed for determining the pathogens responsible for tuberculosis, cholera , and anthrax and for devising Koch's postulates.</li><li>\u27a4 Robert Koch</li><li>\u27a4 German microbiologist;</li><li>\u27a4 Koch's legacy</li><li>\u27a4 germ theory</li><li>\u27a4 famed for determining the pathogens</li><li>\u27a4 tuberculosis, cholera</li><li>\u27a4 anthrax</li><li>\u27a4 devising Koch's postulates.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "2c953a48",
      "audio": ""
    },
    {
      "text": "Which of the following disease does not show ice berg phenomenon?",
      "options": [
        {
          "label": "A",
          "text": "Tuberculosis",
          "correct": false
        },
        {
          "label": "B",
          "text": "Covid 19",
          "correct": false
        },
        {
          "label": "C",
          "text": "Rabies",
          "correct": true
        },
        {
          "label": "D",
          "text": "Japanese encephalitis",
          "correct": false
        }
      ],
      "correct_answer": "C. Rabies",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/12/picture9.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Rabies</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Acute Diseases with no subclinical infections do not show iceberg phenomenon .</li><li>\u2022 Acute Diseases</li><li>\u2022 no subclinical infections</li><li>\u2022 not show iceberg phenomenon</li><li>\u2022 Iceberg phenomenon is not shown by \u2013</li><li>\u2022 Iceberg phenomenon is not shown by \u2013</li><li>\u2022 Measles Tetanus Rabies Rubella</li><li>\u2022 Measles</li><li>\u2022 Tetanus</li><li>\u2022 Rabies</li><li>\u2022 Rubella</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Iceberg phenomenon of disease given by Ernest Hemingway Line of demarcation (water surface): Is between apparent and inapparent infections Epidemiologists study the submerged part of the iceberg , while clinicians deal with the tip of iceberg. Screening is for the submerged section of the iceberg , whereas diagnosis addresses the tip of the iceberg .</li><li>\u27a4 Iceberg phenomenon of disease given by Ernest Hemingway</li><li>\u27a4 Iceberg phenomenon</li><li>\u27a4 Ernest Hemingway</li><li>\u27a4 Line of demarcation (water surface): Is between apparent and inapparent infections</li><li>\u27a4 Line of demarcation</li><li>\u27a4 between apparent</li><li>\u27a4 inapparent infections</li><li>\u27a4 Epidemiologists study the submerged part of the iceberg , while clinicians deal with the tip of iceberg.</li><li>\u27a4 Epidemiologists study</li><li>\u27a4 submerged part of the iceberg</li><li>\u27a4 clinicians deal</li><li>\u27a4 tip of iceberg.</li><li>\u27a4 Screening is for the submerged section of the iceberg , whereas diagnosis addresses the tip of the iceberg .</li><li>\u27a4 Screening</li><li>\u27a4 submerged section</li><li>\u27a4 iceberg</li><li>\u27a4 diagnosis addresses</li><li>\u27a4 tip of the iceberg</li><li>\u27a4 Ref : Park 26 th ed pg 46</li><li>\u27a4 Ref : Park 26 th ed pg 46</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1c85cc1b",
      "audio": ""
    },
    {
      "text": "A 54-year-old man presents to the clinic for a routine check-up. The physician notices the presence of a well-defined transverse crease on the patient\u2019s earlobe. The physician recalls that this physical finding has been associated with an increased risk of ischemic heart disease (IHD) in many studies. The development of a transverse crease on the earlobe is considered a ?",
      "options": [
        {
          "label": "A",
          "text": "Risk factor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Predisposing factor",
          "correct": false
        },
        {
          "label": "C",
          "text": "Risk Marker",
          "correct": true
        },
        {
          "label": "D",
          "text": "Enabling factor",
          "correct": false
        }
      ],
      "correct_answer": "C. Risk Marker",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Risk Marker.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Risk factor: A condition , quality or attribute , the presence of which increases the chances of an individual to have, develop or be adversely affected by a disease process.</li><li>\u2022 Option A. Risk factor:</li><li>\u2022 condition</li><li>\u2022 quality</li><li>\u2022 attribute</li><li>\u2022 presence of which increases</li><li>\u2022 chances of an individual</li><li>\u2022 develop</li><li>\u2022 Option B. Predisposing factors: Factors which create a state of susceptibility , so that the host becomes vulnerable to the agent or to necessary cause.</li><li>\u2022 Option B. Predisposing factors:</li><li>\u2022 create a state of susceptibility</li><li>\u2022 host</li><li>\u2022 vulnerable</li><li>\u2022 Option D. Enabling factors: Are those which assist in the development of (or in recovery from) the disease , e.g. housing conditions, socio-economic status.</li><li>\u2022 Option D. Enabling factors:</li><li>\u2022 assist in the development</li><li>\u2022 disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Recognize that the development of a transverse crease on the earlobe is considered a risk marker for ischemic heart disease , indicating an association with increased risk but not establishing a definitive diagnosis or causal relationship.</li><li>\u27a4 Recognize</li><li>\u27a4 development of a transverse crease</li><li>\u27a4 earlobe</li><li>\u27a4 risk marker for ischemic heart disease</li><li>\u27a4 increased risk</li><li>\u27a4 not establishing a definitive diagnosis</li><li>\u27a4 Ref : Textbook of Community Medicine by Rajvir Balwar 2 nd Ed pg 20.</li><li>\u27a4 Ref : Textbook of Community Medicine by Rajvir Balwar 2 nd Ed pg 20.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ffeeae00",
      "audio": ""
    },
    {
      "text": "A second-year medical student is learning about the progression in epidemiological models used to understand disease causation. Upon discussing the advanced epidemiological triad, which includes additional elements compared to the classic triad, the professor asks the student to identify which of the following is not a component of the advanced epidemiological triad. What should the student\u2019s answer be?",
      "options": [
        {
          "label": "A",
          "text": "Causative factors",
          "correct": false
        },
        {
          "label": "B",
          "text": "Behavioral and cultural factors",
          "correct": false
        },
        {
          "label": "C",
          "text": "Population characteristics",
          "correct": false
        },
        {
          "label": "D",
          "text": "Duration of illness",
          "correct": true
        }
      ],
      "correct_answer": "D. Duration of illness",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/07/image-20230707153254-1.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/07/12/screenshot-2024-07-12-165438.png"
      ],
      "explanation": "<p><strong>Ans. D. Duration of illness.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Epidemiological triad - Agent, host, Environment.</li><li>\u2022 Epidemiological triad</li><li>\u2022 In Advanced model of triangle of epidemiology</li><li>\u2022 Advanced model of triangle</li><li>\u2022 epidemiology</li><li>\u2022 Agent factors are replaced by causative factors Host by Groups or populations and their characteristics Environment factors by Environmental behaviour, culture, Physiological factors, and ecological elements.</li><li>\u2022 Agent factors are replaced by causative factors</li><li>\u2022 Agent factors</li><li>\u2022 replaced</li><li>\u2022 causative factors</li><li>\u2022 Host by Groups or populations and their characteristics</li><li>\u2022 Host by Groups</li><li>\u2022 populations</li><li>\u2022 Environment factors by Environmental behaviour, culture, Physiological factors, and ecological elements.</li><li>\u2022 Environment factors</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Ref : Park 26 th ed pg 40.</li><li>\u27a4 Ref : Park 26 th ed pg 40.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9729327f",
      "audio": ""
    },
    {
      "text": "A medical practitioner is evaluating a 40-year-old man who reports a persistent feeling of tiredness and a lack of energy for several weeks. He states that he is unable to describe exactly what is wrong but feels a general sense of not being well. In clinical terms, the patient's expression of his health status is best categorized as?",
      "options": [
        {
          "label": "A",
          "text": "Disease",
          "correct": false
        },
        {
          "label": "B",
          "text": "Disorder",
          "correct": false
        },
        {
          "label": "C",
          "text": "Illness",
          "correct": true
        },
        {
          "label": "D",
          "text": "Sickness",
          "correct": false
        }
      ],
      "correct_answer": "C. Illness",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Illness</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Disease: Is a physiological/ psychological/ pathological dysfunction . Disease is usually characterized by identifiable signs and symptoms.</li><li>\u2022 Option A. Disease:</li><li>\u2022 physiological/ psychological/ pathological dysfunction</li><li>\u2022 Option B. Disorder : This term is often used to describe a disturbance of normal functioning of the body or mind . Like disease, a disorder is generally characterized by identifiable signs and symptoms.</li><li>\u2022 Option B. Disorder</li><li>\u2022 describe a disturbance of normal functioning</li><li>\u2022 body or mind</li><li>\u2022 Option D. Sickness: Is a state of social dysfunction , i.e., a role that the individual assumes when ill (\"sickness role\").</li><li>\u2022 Option D. Sickness:</li><li>\u2022 state of social dysfunction</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 The objective is to recognize the difference between 'illness' and 'disease. ' 'Illness' is a person's own perception of unwellness , whereas 'disease' is a specific pathological process that can be identified and measured by healthcare professionals.</li><li>\u27a4 objective</li><li>\u27a4 recognize the difference between 'illness' and 'disease.</li><li>\u27a4 'Illness'</li><li>\u27a4 person's own perception of unwellness</li><li>\u27a4 'disease'</li><li>\u27a4 specific pathological process</li><li>\u27a4 identified</li><li>\u27a4 measured by healthcare professionals.</li><li>\u27a4 Ref : Park 26 th ed, pg 39.</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26 th ed, pg 39.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a4a45337",
      "audio": ""
    },
    {
      "text": "In a lecture about the progression of diseases, a professor is explaining various concepts related to disease outcomes and their pathways. He mentions a specific term used to describe the progression of a disease from its initial phase to its conclusion in the absence of any medical intervention. Which of the following terms best describes this concept?",
      "options": [
        {
          "label": "A",
          "text": "Spectrum of health",
          "correct": false
        },
        {
          "label": "B",
          "text": "Epidemiology of disease",
          "correct": false
        },
        {
          "label": "C",
          "text": "Natural history of disease",
          "correct": true
        },
        {
          "label": "D",
          "text": "Spectrum of disease",
          "correct": false
        }
      ],
      "correct_answer": "C. Natural history of disease",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/07/image-20230707155936-1.png"
      ],
      "explanation": "<p><strong>Ans. C. Natural history of disease</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Natural history of disease describes the natural course of the disease from its early pre pathogenesis phases to termination .</li><li>\u2022 Natural history</li><li>\u2022 disease</li><li>\u2022 natural course of the disease</li><li>\u2022 early pre pathogenesis phases</li><li>\u2022 termination</li><li>\u2022 Whereas Epidemiology of a disease involves various factors contributing to disease and Spectrum of disease is a pattern.</li><li>\u2022 Epidemiology of a disease</li><li>\u2022 factors contributing to disease</li><li>\u2022 Spectrum of disease is a pattern.</li><li>\u2022 Educational objective :</li><li>\u2022 Educational objective</li><li>\u2022 :</li><li>\u2022 Natural history of disease is the course a disease takes in individual people from its pathological onset (inception) until its eventual resolution through complete recovery or death , in absence of any intervention</li><li>\u2022 Natural history of disease</li><li>\u2022 course a disease</li><li>\u2022 individual people</li><li>\u2022 pathological onset</li><li>\u2022 eventual resolution through complete recovery or death</li><li>\u2022 Ref : Textbook of Community medicine by Rajvir Balwar, 2 nd ed, pg 21.</li><li>\u2022 Ref</li><li>\u2022 : Textbook of Community medicine by Rajvir Balwar, 2 nd ed, pg 21.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a5308c6e",
      "audio": ""
    },
    {
      "text": "A medical student is reviewing infectious disease terminology in preparation for his exams. He comes across a term that describes a pathogen's capacity to cause noticeable illness in a host. Which of the following terms best defines this concept?",
      "options": [
        {
          "label": "A",
          "text": "Infectivity",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pathogenicity",
          "correct": true
        },
        {
          "label": "C",
          "text": "virulence",
          "correct": false
        },
        {
          "label": "D",
          "text": "Fatality.",
          "correct": false
        }
      ],
      "correct_answer": "B. Pathogenicity",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Pathogenicity</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A. Infectivity: ability of an infectious agent to invade and multiply (produce infection) in a host .</li><li>\u2022 Option A. Infectivity:</li><li>\u2022 ability</li><li>\u2022 infectious agent</li><li>\u2022 invade and multiply</li><li>\u2022 host</li><li>\u2022 Option C. Virulence: proportion of clinical cases resulting in severe clinical manifestations (including sequelae).</li><li>\u2022 Option C. Virulence:</li><li>\u2022 proportion</li><li>\u2022 clinical cases</li><li>\u2022 severe clinical manifestations</li><li>\u2022 Option D. Fatality: Death due to disease .</li><li>\u2022 Option D. Fatality:</li><li>\u2022 Death</li><li>\u2022 disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Define pathogenicity as a pathogen's ability to produce clinically apparent illness in a host , distinguishing it from other related infectious disease terms.</li><li>\u27a4 Define pathogenicity</li><li>\u27a4 pathogen's ability</li><li>\u27a4 produce</li><li>\u27a4 clinically apparent illness</li><li>\u27a4 host</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "32f43aef",
      "audio": ""
    },
    {
      "text": "An epidemiologist is conducting a workshop for medical students on disease progression and diagnosis. During the session, she uses the metaphor of an iceberg to explain the prevalence of certain diseases within the community. While the tip of the iceberg represents those cases that are overt and diagnosed, the submerged part denotes those not readily visible or diagnosed. The submerged portion is often much larger and represents a significant part of the affected population. Which of the following does NOT accurately characterize this submerged portion of the iceberg metaphor?",
      "options": [
        {
          "label": "A",
          "text": "Diagnosed cases under treatment",
          "correct": true
        },
        {
          "label": "B",
          "text": "Undiagnosed cases",
          "correct": false
        },
        {
          "label": "C",
          "text": "Carriers sub clinical cases",
          "correct": false
        },
        {
          "label": "D",
          "text": "Latent & Healthy population",
          "correct": false
        }
      ],
      "correct_answer": "A. Diagnosed cases under treatment",
      "question_images": [],
      "explanation_images": [
        "https://lh7-us.googleusercontent.com/ES9xLBLtQI7HCou48VYPY3HMlxMB3xYC5Sic3QyKDvVQDu9FsyzUxRTPRkaghUzwJCNghiYzhBiFWWrieWVHlusf47ACGeezeJlsdpJmbELaZ5yTO27jPotlskB1EqEQ4_wSu57w5EhBAArINmLCw_M"
      ],
      "explanation": "<p><strong>Ans. A. Diagnosed cases under treatment</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Iceberg Phenomenon of disease: Disease in a community may be compared to an iceberg Floating tip is what physician sees in community, i.e.,clinical cases Vast submerged portion of iceberg represents hidden mass of disease, i.e., latent, inapparent, presymptomatic and undiagnosed cases and carriers in community Line of demarcation (water surface): Is between apparent and inapparent infections Water surrounding iceberg: Healthy population</li><li>\u2022 Iceberg Phenomenon of disease: Disease in a community may be compared to an iceberg Floating tip is what physician sees in community, i.e.,clinical cases Vast submerged portion of iceberg represents hidden mass of disease, i.e., latent, inapparent, presymptomatic and undiagnosed cases and carriers in community Line of demarcation (water surface): Is between apparent and inapparent infections Water surrounding iceberg: Healthy population</li><li>\u2022 Floating tip is what physician sees in community, i.e.,clinical cases Vast submerged portion of iceberg represents hidden mass of disease, i.e., latent, inapparent, presymptomatic and undiagnosed cases and carriers in community Line of demarcation (water surface): Is between apparent and inapparent infections Water surrounding iceberg: Healthy population</li><li>\u2022 Floating tip is what physician sees in community, i.e.,clinical cases</li><li>\u2022 Vast submerged portion of iceberg represents hidden mass of disease, i.e., latent, inapparent, presymptomatic and undiagnosed cases and carriers in community</li><li>\u2022 Line of demarcation (water surface): Is between apparent and inapparent infections</li><li>\u2022 Water surrounding iceberg: Healthy population</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 \u2018Epidemiologist is concerned with Hidden portion of iceberg\u2019 whereas Clinician is concerned with Tip of iceberg \u2018Screening is done for Hidden portion of Iceberg\u2019 whereas diagnosis is done for tip of iceberg Iceberg phenomenon of disease is not shown by: Rabies Tetanus Measles Rubella</li><li>\u27a4 \u2018Epidemiologist is concerned with Hidden portion of iceberg\u2019 whereas Clinician is concerned with Tip of iceberg</li><li>\u27a4 \u2018Screening is done for Hidden portion of Iceberg\u2019 whereas diagnosis is done for tip of iceberg</li><li>\u27a4 Iceberg phenomenon of disease is not shown by: Rabies Tetanus Measles Rubella</li><li>\u27a4 Rabies Tetanus Measles Rubella</li><li>\u27a4 Rabies</li><li>\u27a4 Tetanus</li><li>\u27a4 Measles</li><li>\u27a4 Rubella</li><li>\u27a4 Ref : Park 27 th ed, pg 46</li><li>\u27a4 Ref : Park 27 th ed, pg 46</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fd518ea2",
      "audio": ""
    },
    {
      "text": "A 75-year-old female patient with a past medical history of arthritis and mild cognitive impairment is brought to your clinic by her daughter, who is concerned about her mother's ability to perform daily activities independently. You decide to conduct a comprehensive evaluation to determine the patient's functional status and need for assistance. Considering various indices to measure disability, which of the following would be the most appropriate to exclude from your assessment if you are specifically focusing on the patient\u2019s physical and cognitive ability to perform daily activities?",
      "options": [
        {
          "label": "A",
          "text": "\u200b\u200b\u200b\u200b Health Adjusted Life expectancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Sullivan\u2019s index",
          "correct": false
        },
        {
          "label": "C",
          "text": "Quality adjusted life years",
          "correct": false
        },
        {
          "label": "D",
          "text": "Physical Quality of Life Index",
          "correct": true
        }
      ],
      "correct_answer": "D. Physical Quality of Life Index",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Physical Quality of Life Index</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 Option A . HALE : Health-adjusted life expectancy : Equivalent number of years in \u201cfull health\u201d that a new-born can expect to live based on current rates of ill health and mortality</li><li>\u2022 Option A</li><li>\u2022 HALE</li><li>\u2022 Health-adjusted life expectancy</li><li>\u2022 Equivalent number of years in \u201cfull health\u201d</li><li>\u2022 new-born can expect to live</li><li>\u2022 current rates of ill health</li><li>\u2022 mortality</li><li>\u2022 Option B . Sullivan\u2019s Index, now called DFLE (Disability-free life expectancy), means the average number of years an individual is expected to live free of disability (given the current mortality and disability). It is calculated as Life expectancy minus duration of disability</li><li>\u2022 Option B</li><li>\u2022 Sullivan\u2019s Index,</li><li>\u2022 DFLE</li><li>\u2022 average number of years</li><li>\u2022 individual is expected to live free of disability</li><li>\u2022 Life expectancy minus duration of disability</li><li>\u2022 Option C . QALY (Quality Adjusted Life Years) is the measure of both quality and quantity of life lived . It is the years of life lived in perfect health and gives the best assessment of cost-effectiveness of the intervention.</li><li>\u2022 Option C</li><li>\u2022 QALY</li><li>\u2022 measure of both quality</li><li>\u2022 quantity of life lived</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Following are the measures of Disability Rates:</li><li>\u27a4 QALY (Quality Adjusted Life Years) - QALY is a measure of both quality and quantity of life lived. QALY is years of life lived in perfect health. DALY (Disability Adjusted Life Years) - DALY is BEST measure of burden of disease in a defined population DFLE (Disability free life expectancy) = Sullivan's index</li><li>\u27a4 QALY (Quality Adjusted Life Years) - QALY is a measure of both quality and quantity of life lived. QALY is years of life lived in perfect health.</li><li>\u27a4 QALY</li><li>\u27a4 DALY (Disability Adjusted Life Years) - DALY is BEST measure of burden of disease in a defined population</li><li>\u27a4 DALY</li><li>\u27a4 DFLE (Disability free life expectancy) = Sullivan's index</li><li>\u27a4 DFLE</li><li>\u27a4 Ref : Park 26 th ed, pg 26.</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26 th ed, pg 26.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "44911fca",
      "audio": ""
    },
    {
      "text": "A 48-year-old policy maker is evaluating different indices to understand the overall health status of a population in a particular region. He comes across the Physical Quality of Life Index (PQLI) and wants to understand its components and utilization better. Which of the following statements about the PQLI is NOT true?",
      "options": [
        {
          "label": "A",
          "text": "Performance ranges between 0-1",
          "correct": true
        },
        {
          "label": "B",
          "text": "Includes IMR, Life expectancy at age 1 and literacy rate",
          "correct": false
        },
        {
          "label": "C",
          "text": "PQLI doesn\u2019t not measure economic growth",
          "correct": false
        },
        {
          "label": "D",
          "text": "Sri Lanka has high PQLI",
          "correct": false
        }
      ],
      "correct_answer": "A. Performance ranges between 0-1",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/03/screenshot-2024-04-03-182754.jpg"
      ],
      "explanation": "<p><strong>Ans. A. Performance ranges between 0-1</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 PQLI consolidates three indicators - infant mortality , life expectancy at age one , and literacy . It is calculated by averaging the three indicators , giving equal weight to each of them . The resulting PQLI thus is scaled 0 to 100. Sri Lanka and Kerala state in India have low per capita incomes with high PQLIs . PQLI does not measure economic growth; it measures the results of social, economic and political policies</li><li>\u2022 PQLI consolidates three indicators - infant mortality , life expectancy at age one , and literacy . It is calculated by averaging the three indicators , giving equal weight to each of them . The resulting PQLI thus is scaled 0 to 100.</li><li>\u2022 PQLI consolidates three indicators</li><li>\u2022 infant mortality</li><li>\u2022 life expectancy at age one</li><li>\u2022 literacy</li><li>\u2022 calculated</li><li>\u2022 averaging the three indicators</li><li>\u2022 equal weight to each of them</li><li>\u2022 Sri Lanka and Kerala state in India have low per capita incomes with high PQLIs .</li><li>\u2022 Sri Lanka</li><li>\u2022 Kerala state in India</li><li>\u2022 low per capita incomes</li><li>\u2022 high PQLIs</li><li>\u2022 PQLI does not measure economic growth; it measures the results of social, economic and political policies</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 HDI Vs PQLI</li><li>\u27a4 HDI Vs PQLI</li><li>\u27a4 Ref : Park 26 th ed, pg 17.</li><li>\u27a4 Ref : Park 26 th ed, pg 17.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "bdf2e7d5",
      "audio": ""
    },
    {
      "text": "A public health administrator is working on a global health project to assess the developmental progress of various countries. One of her tasks is to classify countries based on their Human Development Index (HDI) to better allocate resources and design interventions. The HDI is a composite index that assesses a country's average achievements in three basic aspects of human development: health, knowledge, and standard of living. Given this context, how would the administrator categorize India based on its HDI ranking?",
      "options": [
        {
          "label": "A",
          "text": "Low",
          "correct": false
        },
        {
          "label": "B",
          "text": "Very low",
          "correct": false
        },
        {
          "label": "C",
          "text": "Medium",
          "correct": true
        },
        {
          "label": "D",
          "text": "High",
          "correct": false
        }
      ],
      "correct_answer": "C. Medium",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/screenshot-2024-04-04-142523.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/screenshot-2024-04-04-142615_kzj4S3d.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/picture3_Ffiok8Y.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Medium</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 India\u2019s HDI for 2021 - 0.633.</li><li>\u2022 HDI is a composite index measuring average achievement in three basic dimensions of human development :</li><li>\u2022 HDI</li><li>\u2022 composite index</li><li>\u2022 average achievement</li><li>\u2022 three basic dimensions of human development</li><li>\u2022 Long and healthy life : Life expectancy at birth. Knowledge : Measured by a combination of expected years of schooling and mean years of schooling. Decent standard of living : Measured by Gross National Income (GNI) per capita.</li><li>\u2022 Long and healthy life : Life expectancy at birth.</li><li>\u2022 Long and healthy life</li><li>\u2022 Knowledge : Measured by a combination of expected years of schooling and mean years of schooling.</li><li>\u2022 Knowledge</li><li>\u2022 Decent standard of living : Measured by Gross National Income (GNI) per capita.</li><li>\u2022 Decent standard of living</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 HDI values range : 0 to + 1 (HDI of India is 0.633 & Rank is 130 out of 189 countries) Human poverty index [HPI] is complementary to HDI</li><li>\u27a4 HDI values range : 0 to + 1 (HDI of India is 0.633 & Rank is 130 out of 189 countries)</li><li>\u27a4 HDI values range</li><li>\u27a4 0 to + 1</li><li>\u27a4 Human poverty index [HPI] is complementary to HDI</li><li>\u27a4 Human poverty index</li><li>\u27a4 complementary to HDI</li><li>\u27a4 Ref : Park 26 th ed, pg 18, Human Development Report 2021-22- UNDP</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26 th ed, pg 18, Human Development Report 2021-22- UNDP</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "25b46788",
      "audio": ""
    },
    {
      "text": "To analyze the overall health and longevity of a population, a public health specialist reviews various mortality and health-related indicators. He understands that most of the following indicators provide insights into the mortality rates and life expectancy. Among the following indicators, which one does NOT primarily measure mortality?",
      "options": [
        {
          "label": "A",
          "text": "Life expectancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "Years of Potential life lost",
          "correct": false
        },
        {
          "label": "C",
          "text": "Case fatality rate",
          "correct": false
        },
        {
          "label": "D",
          "text": "HALE",
          "correct": true
        }
      ],
      "correct_answer": "D. HALE",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/11/picture2_5SlC70B.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/screenshot-2024-04-04-144547.jpg"
      ],
      "explanation": "<p><strong>Ans. D. HALE</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A . Life Expectancy is the average number of additional years that a man is expected to live . It is commonly measured as Life expectancy at birth. It is a positive mortality indicator.</li><li>\u2022 Option A</li><li>\u2022 Life Expectancy</li><li>\u2022 average number of additional years</li><li>\u2022 expected to live</li><li>\u2022 Option B . Years of Potential Life Lost : It is based on the years of life lost through premature death . It is a type of mortality indicator.</li><li>\u2022 Option B</li><li>\u2022 Years of Potential Life Lost</li><li>\u2022 years of life lost</li><li>\u2022 premature death</li><li>\u2022 Option C . Case Fatality Rate: It is the number of deaths among the cases of a specific disease in a specified amount of time . It is mortality indicator and it depicts the virulence of the organism. It is typically used for acute infections.</li><li>\u2022 Option C</li><li>\u2022 Case Fatality Rate:</li><li>\u2022 number of deaths</li><li>\u2022 cases of a specific disease</li><li>\u2022 specified amount of time</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Ref : Park 26 th ed, pg 26.</li><li>\u27a4 Ref : Park 26 th ed, pg 26.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "09436957",
      "audio": ""
    },
    {
      "text": "A public health expert is educating a group of medical students about various models used to understand the complexity of disease causation. He introduces the concept of the \"web of causation,\" then presents a list of characteristics related to it and asks the students to identify which statement does NOT accurately describe this model?",
      "options": [
        {
          "label": "A",
          "text": "It considers all the predisposing factors and their complex inter relationship with each other.",
          "correct": false
        },
        {
          "label": "B",
          "text": "Removal or elimination of just one major link that is sufficiently important in pathogenic process is sufficient to control disease.",
          "correct": false
        },
        {
          "label": "C",
          "text": "It shows the possible interventions that can be taken to reduce the occurrence of disease.",
          "correct": false
        },
        {
          "label": "D",
          "text": "It implies that, at all instances, all the chains of causation must be controlled to prevent the disease.",
          "correct": true
        }
      ],
      "correct_answer": "D. It implies that, at all instances, all the chains of causation must be controlled to prevent the disease.",
      "question_images": [],
      "explanation_images": [
        "https://lh7-us.googleusercontent.com/i9r4SEVFrbnH3A2dgRjd3YdIcT_RcsHulfV6DHBAvD14ztE1Q_NDpt-fmM8wkmZrtU2VuUWXJXhAEylv4L62dDS0-jZoQbKWXO9mc3UK2ep3HyaJzNMAo5rWulUSMl2foiyoVh80JGMpdCVxcdLTIVI"
      ],
      "explanation": "<p><strong>Ans. D.\u00a0It implies that individual facts in the chain have equal weightage and all the chains of causation must be controlled to prevent the disease.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Model \"Web of causation\" - proposed by McMohan and Pugh</li><li>\u2022 \"Web of causation\"</li><li>\u2022 McMohan and Pugh</li><li>\u2022 The web of causation considers all the predisposing factors and their complex interrelationship with each other . This model is ideally suited to study chronic disease . The web of causation does not imply that the disease is controlled only when all the multiple chains of causation are removed.</li><li>\u2022 web of causation</li><li>\u2022 predisposing factors</li><li>\u2022 complex interrelationship with each other</li><li>\u2022 model is ideally suited</li><li>\u2022 study chronic disease</li><li>\u2022 For preventing a disease , it is not necessary to take action against all the factors -identifying the \u201cweakest links\u201d in the inter-lacing webs , actions directed to these weakest links may be of considerable value in prevention.</li><li>\u2022 preventing a disease</li><li>\u2022 take action against all the factors</li><li>\u2022 \u201cweakest links\u201d</li><li>\u2022 inter-lacing webs</li><li>\u2022 actions directed</li><li>\u2022 weakest links</li><li>\u2022 value in prevention.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 The educational objective is to understand the \"web of causation\" model in public health , which is used to describe the complex and interconnected factors leading to the development of diseases . This model highlights that disease prevention and intervention can be multifaceted and does not require the control of all factors, challenging the simplistic linear chain of causation approach.</li><li>\u27a4 \"web of causation\" model</li><li>\u27a4 public health</li><li>\u27a4 complex</li><li>\u27a4 interconnected factors</li><li>\u27a4 development of diseases</li><li>\u27a4 model highlights</li><li>\u27a4 disease prevention</li><li>\u27a4 intervention</li><li>\u27a4 multifaceted</li><li>\u27a4 Ref : Park 26 th ed pg 41.</li><li>\u27a4 Ref : Park 26 th ed pg 41.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "9c4e8ee2",
      "audio": ""
    },
    {
      "text": "Human development Index is a composite of all of the following parameters, except?",
      "options": [
        {
          "label": "A",
          "text": "Level of schooling",
          "correct": false
        },
        {
          "label": "B",
          "text": "Economic status",
          "correct": false
        },
        {
          "label": "C",
          "text": "Life expectancy at birth",
          "correct": false
        },
        {
          "label": "D",
          "text": "Infant Mortality rate",
          "correct": true
        }
      ],
      "correct_answer": "D. Infant Mortality rate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/04/screenshot-2024-04-04-144952.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Infant Mortality rate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Human development index (HDI) is a composite index which includes three basic dimensions of human development :</li><li>\u2022 Human development index</li><li>\u2022 composite index</li><li>\u2022 three basic dimensions</li><li>\u2022 human development</li><li>\u2022 To lead a long and healthy life - measured by life expectancy at birth. The ability to acquire knowledge - measured by mean years of schooling and expected years of schooling The ability to achieve decent standard of living - measured by gross national income per capita in PPP US $</li><li>\u2022 To lead a long and healthy life - measured by life expectancy at birth.</li><li>\u2022 To lead a long and healthy life</li><li>\u2022 The ability to acquire knowledge - measured by mean years of schooling and expected years of schooling</li><li>\u2022 The ability to acquire knowledge</li><li>\u2022 The ability to achieve decent standard of living - measured by gross national income per capita in PPP US $</li><li>\u2022 The ability to achieve decent standard of living</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Ref : Park 26 th ed, pg 17.</li><li>\u27a4 Ref : Park 26 th ed, pg 17.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0d14da29",
      "audio": ""
    },
    {
      "text": "In the context of public health, factors that facilitate the development of a disease or aid in recovery from an illness are crucial for understanding health outcomes. These factors can either expose individuals to higher risk or enhance their ability to cope and recover. Which term best describes these elements?",
      "options": [
        {
          "label": "A",
          "text": "Predisposing factor",
          "correct": false
        },
        {
          "label": "B",
          "text": "Enabling factor",
          "correct": true
        },
        {
          "label": "C",
          "text": "Precipitating factor",
          "correct": false
        },
        {
          "label": "D",
          "text": "Reinforcing factor.",
          "correct": false
        }
      ],
      "correct_answer": "B. Enabling factor",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Enabling factor</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Predisposing factors: Factors which create a state of susceptibility , so that the host becomes vulnerable to the agent or to necessary cause, e.g. age, sex, previous illness.</li><li>\u2022 Option A. Predisposing factors:</li><li>\u2022 create a state of susceptibility</li><li>\u2022 host becomes vulnerable</li><li>\u2022 agent</li><li>\u2022 Option C. Precipitating factors: Are those that are associated with immediate exposure to the disease agent or onset of disease, e.g. drinking contaminated water, close contact with an open case of pulmonary TB.</li><li>\u2022 Option C. Precipitating factors:</li><li>\u2022 associated with immediate exposure</li><li>\u2022 disease agent</li><li>\u2022 Option D. Reinforcing factors: Are those which aggravate an already existing disease , e.g. malnutrition, repeated, exposures, etc.</li><li>\u2022 Option D. Reinforcing factors:</li><li>\u2022 aggravate an already existing disease</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Enabling factors specifically refer to conditions that facilitate the development of a disease or support the recovery process , which can be essential for designing effective health interventions and recovery programs .</li><li>\u27a4 Enabling factors</li><li>\u27a4 conditions that facilitate the development of a disease</li><li>\u27a4 support the recovery process</li><li>\u27a4 designing effective health interventions</li><li>\u27a4 recovery programs</li><li>\u27a4 Ref : AFMC Red Book pg 20</li><li>\u27a4 Ref : AFMC Red Book pg 20</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "044e7c27",
      "audio": ""
    },
    {
      "text": "Sensitive indicator on availability, utilization and effectiveness of health care services in a country is?",
      "options": [
        {
          "label": "A",
          "text": "Life expectancy",
          "correct": false
        },
        {
          "label": "B",
          "text": "DALY",
          "correct": false
        },
        {
          "label": "C",
          "text": "Infant Mortality rate",
          "correct": true
        },
        {
          "label": "D",
          "text": "Hospital bed occupancy rate",
          "correct": false
        }
      ],
      "correct_answer": "C. Infant Mortality rate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/07/image-20230707113454-1.png",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/23/screenshot-2023-08-11-1921039020.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Infant Mortality rate</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A . Life Expectancy : It is the average number of additional years that a person of a given age can expect to live . Most common measure of life expectancy is life expectancy at birth. Currently, it is 70.42 years (2023).</li><li>\u2022 Option A</li><li>\u2022 Life Expectancy</li><li>\u2022 average number of additional years</li><li>\u2022 person of a given age can expect to live</li><li>\u2022 Option B . DALY is disability-adjusted life years , which is the best measure of disease burden , including both reduction in life expectancy and diminished quality of life. It can measure both mortality and disability together.</li><li>\u2022 Option B</li><li>\u2022 DALY</li><li>\u2022 disability-adjusted life years</li><li>\u2022 best measure of disease burden</li><li>\u2022 DALY = YLL (years of life lost) + YLD (years lost to disability)</li><li>\u2022 Option C. Hospital bed occupancy rate - Is calculated as the number of hospital bed-days related to curative care divided by the number of available curative care beds (multiplied by 365).</li><li>\u2022 Option C.</li><li>\u2022 Hospital bed occupancy rate</li><li>\u2022 calculated</li><li>\u2022 number of hospital bed-days</li><li>\u2022 curative care</li><li>\u2022 divided</li><li>\u2022 number of available curative care beds</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Ref : Park 26th ed, pg25.</li><li>\u27a4 Ref : Park 26th ed, pg25.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a4e00fab",
      "audio": ""
    },
    {
      "text": "A 35-year-old woman from Brazil arrives at a major international airport in India. She is scheduled to travel to various rural areas in India for a pilgrimage. She is in good health and has no history of recent illnesses. As the airport's medical officer reviewing her health documentation, you note that she has completed most recommended vaccinations for travel. Considering her origin and travel plans, which of the following vaccination certificates is most important to verify for her?",
      "options": [
        {
          "label": "A",
          "text": "Hepatitis A",
          "correct": false
        },
        {
          "label": "B",
          "text": "BCG",
          "correct": false
        },
        {
          "label": "C",
          "text": "Japanese encephalitis",
          "correct": false
        },
        {
          "label": "D",
          "text": "Yellow fever",
          "correct": true
        }
      ],
      "correct_answer": "D. Yellow fever",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. Yellow fever</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Hepatitis A: Hepatitis A vaccination is generally recommended for travelers to areas with high endemicity. It's not specifically required for entry into India .</li><li>\u2022 Option A. Hepatitis A:</li><li>\u2022 travelers</li><li>\u2022 high endemicity.</li><li>\u2022 not</li><li>\u2022 entry into India</li><li>\u2022 Option B. BCG: It's not a standard travel vaccine.</li><li>\u2022 Option B. BCG:</li><li>\u2022 not</li><li>\u2022 Option C. Japanese Encephalitis: This vaccine is recommended for travelers to Asia who will be spending a lot of time outdoors in rural areas , but it's not a standard requirement for entry into India.</li><li>\u2022 Option C. Japanese Encephalitis:</li><li>\u2022 travelers to Asia</li><li>\u2022 spending</li><li>\u2022 outdoors in rural areas</li><li>\u2022 not</li><li>\u2022 entry into India.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 India is a \u2018Yellow Fever receptive\u2019 area: Population is unvaccinated and susceptible to Yellow Fever . Under IHR Travellers must possess a valid International certificate of vaccination ( validity 10 days\u2013Lifelong ) against YF before they enter \u2018YF receptive areas\u2019</li><li>\u27a4 India is a \u2018Yellow Fever receptive\u2019 area: Population is unvaccinated and susceptible to Yellow Fever .</li><li>\u27a4 India</li><li>\u27a4 \u2018Yellow Fever receptive\u2019</li><li>\u27a4 unvaccinated</li><li>\u27a4 susceptible</li><li>\u27a4 Yellow Fever</li><li>\u27a4 Under IHR Travellers must possess a valid International certificate of vaccination ( validity 10 days\u2013Lifelong ) against YF before they enter \u2018YF receptive areas\u2019</li><li>\u27a4 IHR Travellers</li><li>\u27a4 valid International certificate</li><li>\u27a4 validity 10 days\u2013Lifelong</li><li>\u27a4 YF before</li><li>\u27a4 enter \u2018YF receptive areas\u2019</li><li>\u27a4 Ref : PARK 26 th ed 324</li><li>\u27a4 Ref</li><li>\u27a4 : PARK 26 th ed 324</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "83a57452",
      "audio": ""
    },
    {
      "text": "A medical student is reviewing concepts of immunology. While discussing active immunity, the student is asked to identify which of the following methods does NOT confer active immunity. Which option should the student choose?",
      "options": [
        {
          "label": "A",
          "text": "Exposure to infections",
          "correct": false
        },
        {
          "label": "B",
          "text": "Inoculation of Immunoglobulins",
          "correct": true
        },
        {
          "label": "C",
          "text": "Immunization with killed vaccine",
          "correct": false
        },
        {
          "label": "D",
          "text": "Exposure to subclinical infection",
          "correct": false
        }
      ],
      "correct_answer": "B. Inoculation of Immunoglobulins",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Inoculation of Immunoglobulins</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Active immunity may be acquired in 3 ways:</li><li>\u2022 Active immunity may be acquired in 3 ways:</li><li>\u2022 Option A. Exposure to infections: Following clinical infection, e.g., chickenpox, rubella, and measles.</li><li>\u2022 Option A. Exposure to infections:</li><li>\u2022 clinical</li><li>\u2022 chickenpox, rubella, and measles.</li><li>\u2022 Option C. Immunization with killed vaccine: Following immunization with an antigen which may be a killed vaccine, a live attenuated vaccine, or toxoid.</li><li>\u2022 Option C. Immunization with killed vaccine:</li><li>\u2022 immunization</li><li>\u2022 antigen</li><li>\u2022 killed vaccine, a live attenuated vaccine, or toxoid.</li><li>\u2022 Option D. Exposure to subclinical infection: Following subclinical or inapparent infection, e.g., polio and diphtheria.</li><li>\u2022 Option D. Exposure to subclinical infection:</li><li>\u2022 inapparent</li><li>\u2022 polio and diphtheria.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Active immunity may be acquired through clinical or subclinical infection or immunization, while Immunoglobins render passive immunity.</li><li>\u27a4 Active immunity</li><li>\u27a4 acquired</li><li>\u27a4 clinical or subclinical infection or immunization,</li><li>\u27a4 Immunoglobins</li><li>\u27a4 passive immunity.</li><li>\u27a4 Ref: Park 26 th ed pg 109.</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 109.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "e0ef4c92",
      "audio": ""
    },
    {
      "text": "A 28-year-old man, planning an adventurous journey to a region known for exotic infectious diseases, consults a travel clinic for necessary immunizations. During his visit, he receives a vaccine to protect against a specific pathogen prevalent in his travel destination. In the context of his body's immune response to this vaccine, which type of antibody will his immune system predominantly produce first? This initial antibody plays a pivotal role in the primary immune response, acting as the first line of defense against new pathogens.",
      "options": [
        {
          "label": "A",
          "text": "IgG",
          "correct": false
        },
        {
          "label": "B",
          "text": "IgM",
          "correct": true
        },
        {
          "label": "C",
          "text": "IgA",
          "correct": false
        },
        {
          "label": "D",
          "text": "IgD",
          "correct": false
        }
      ],
      "correct_answer": "B. IgM",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. IgM</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Types of immunoglobulins -</li><li>\u2022 Types of immunoglobulins -</li><li>\u2022 IgG: Comprises 85% of total serum immunoglobulins, largely extravascular , the only class of immunoglobulins to cross the placenta.</li><li>\u2022 IgG:</li><li>\u2022 85%</li><li>\u2022 total serum immunoglobulins,</li><li>\u2022 extravascular</li><li>\u2022 cross the placenta.</li><li>\u2022 IgM: Comprises 10% of total serum immunoglobulins , indicative of recent infection, has high agglutinating and complement-fixating ability.</li><li>\u2022 IgM:</li><li>\u2022 10% of total serum immunoglobulins</li><li>\u2022 recent infection,</li><li>\u2022 high agglutinating</li><li>\u2022 complement-fixating</li><li>\u2022 IgA: Comprises 15% of total serum immunoglobulins, predominantly found in secretions, primary defence mechanism at mucous membranes</li><li>\u2022 IgA:</li><li>\u2022 15% of total serum immunoglobulins,</li><li>\u2022 found</li><li>\u2022 secretions,</li><li>\u2022 defence</li><li>\u2022 mucous membranes</li><li>\u2022 IgD: Exact function not known</li><li>\u2022 IgD:</li><li>\u2022 not known</li><li>\u2022 IgE : Concentrated in submucous tissues , responsible for immediate allergic anaphylaxis reaction.</li><li>\u2022 IgE</li><li>\u2022 submucous tissues</li><li>\u2022 immediate allergic anaphylaxis reaction.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Identify IgM as the first type of antibody produced in the primary immune response following initial vaccination or antigen exposure .</li><li>\u27a4 Identify IgM</li><li>\u27a4 first</li><li>\u27a4 antibody</li><li>\u27a4 primary immune response</li><li>\u27a4 vaccination or antigen exposure</li><li>\u27a4 Ref : Park 26th ed pg 109.</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26th ed pg 109.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3d4c5663",
      "audio": ""
    },
    {
      "text": "In a workshop on public health, a medical officer emphasizes the importance of herd immunity in preventing outbreaks. Later, during a breakout session, participants brainstorm on factors that influence herd immunity. Which of the following factors raised by a participant does NOT play a significant role in establishing or maintaining herd immunity?",
      "options": [
        {
          "label": "A",
          "text": "Subclinical infection",
          "correct": false
        },
        {
          "label": "B",
          "text": "Immunization of herd",
          "correct": false
        },
        {
          "label": "C",
          "text": "Herd structure",
          "correct": false
        },
        {
          "label": "D",
          "text": "Immunity through maternal antibodies",
          "correct": true
        }
      ],
      "correct_answer": "D. Immunity through maternal antibodies",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. \u00a0Immunity through maternal antibodies</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Occurrence of clinical and subclinical infection in the herd.</li><li>\u2022 Option A.</li><li>\u2022 clinical and subclinical infection</li><li>\u2022 Option B. Immunization of the herd.</li><li>\u2022 Option B. Immunization</li><li>\u2022 Option C. Herd structure (hosts, alternative animal hosts, insect vectors, environmental & social factors).</li><li>\u2022 Option C.</li><li>\u2022 Herd structure</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Herd immunity is the indirect protection from an infectious disease that happens when a population is immune either through vaccination or immunity developed through previous infection . It is neither possible nor necessary to achieve 100% herd immunity to control a disease . Herd immunity may be determined by Serological Surveys .</li><li>\u27a4 Herd immunity</li><li>\u27a4 indirect</li><li>\u27a4 protection</li><li>\u27a4 infectious disease</li><li>\u27a4 population</li><li>\u27a4 immune</li><li>\u27a4 vaccination or immunity</li><li>\u27a4 previous infection</li><li>\u27a4 neither</li><li>\u27a4 nor</li><li>\u27a4 achieve</li><li>\u27a4 100% herd immunity</li><li>\u27a4 control</li><li>\u27a4 disease</li><li>\u27a4 determined</li><li>\u27a4 Serological Surveys</li><li>\u27a4 Ref: Park 26 th ed pg 110.</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 110.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4e361a4e",
      "audio": ""
    },
    {
      "text": "A public health official is addressing a group of healthcare professionals about the critical role of vaccinations in controlling infectious diseases. The official emphasizes the concept of herd immunity, which occurs when a significant portion of a community is vaccinated, thereby providing indirect protection to those who are not vaccinated. This phenomenon can effectively prevent the spread of certain infectious diseases. However, not all diseases can be controlled through herd immunity. The official poses a question to the audience: Among following diseases, which one does NOT benefit from herd immunity?",
      "options": [
        {
          "label": "A",
          "text": "Diphtheria",
          "correct": false
        },
        {
          "label": "B",
          "text": "Poliomyelitis",
          "correct": false
        },
        {
          "label": "C",
          "text": "Tetanus",
          "correct": true
        },
        {
          "label": "D",
          "text": "Measles",
          "correct": false
        }
      ],
      "correct_answer": "C. Tetanus",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-154429_HY7EM4y.jpg"
      ],
      "explanation": "<p><strong>Ans. C. Tetanus</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Options: In the cases of Diphtheria (Option A), Poliomyelitis (Option B), and Measles (Option D ), the pathogens are transmitted between individuals , and a high level of community immunity can prevent their spread, protecting even those who are not immunized . High vaccination rates in a population can provide herd immunity , reducing the likelihood of outbreaks .</li><li>\u2022 Options:</li><li>\u2022 Diphtheria (Option A), Poliomyelitis (Option B), and Measles (Option D</li><li>\u2022 pathogens</li><li>\u2022 transmitted</li><li>\u2022 between individuals</li><li>\u2022 high level</li><li>\u2022 prevent</li><li>\u2022 protecting</li><li>\u2022 not immunized</li><li>\u2022 High vaccination rates</li><li>\u2022 herd immunity</li><li>\u2022 reducing</li><li>\u2022 outbreaks</li><li>\u2022 Herd Immunity is the level of resistance of a community or group of people to a particular disease . It refers to group protection beyond what is afforded by the protection of immunized individuals . It helps to protect vulnerable people like babies , the elderly and to those who are immunocompromised.</li><li>\u2022 Herd Immunity</li><li>\u2022 level of resistance</li><li>\u2022 particular disease</li><li>\u2022 group protection</li><li>\u2022 afforded</li><li>\u2022 protection of immunized individuals</li><li>\u2022 protect vulnerable people</li><li>\u2022 babies</li><li>\u2022 elderly</li><li>\u2022 immunocompromised.</li><li>\u2022 Elements contributing to herd immunity are the occurrence of clinical/subclinical infections in herd, immunization of the herd , and structure of the herd (hosts, alternative animal hosts, insect vectors, environmental & social factors). It is neither possible nor necessary to achieve 100% herd immunity to control a disease . Herd immunity may be determined by Serological Surveys . Herd immunity describes a type of immunity that occurs when the vaccination of a portion of the population (or herd) protects un-vaccinated individuals .</li><li>\u2022 Elements contributing to herd immunity are the occurrence of clinical/subclinical infections in herd, immunization of the herd , and structure of the herd (hosts, alternative animal hosts, insect vectors, environmental & social factors).</li><li>\u2022 Elements</li><li>\u2022 herd immunity</li><li>\u2022 clinical/subclinical</li><li>\u2022 infections in herd, immunization</li><li>\u2022 herd</li><li>\u2022 structure</li><li>\u2022 herd</li><li>\u2022 It is neither possible nor necessary to achieve 100% herd immunity to control a disease .</li><li>\u2022 neither possible nor necessary</li><li>\u2022 100% herd immunity</li><li>\u2022 control a disease</li><li>\u2022 Herd immunity may be determined by Serological Surveys .</li><li>\u2022 determined</li><li>\u2022 Serological Surveys</li><li>\u2022 Herd immunity describes a type of immunity that occurs when the vaccination of a portion of the population (or herd) protects un-vaccinated individuals .</li><li>\u2022 Herd immunity</li><li>\u2022 type of immunity</li><li>\u2022 vaccination</li><li>\u2022 population (or herd) protects un-vaccinated individuals</li><li>\u2022 Herd Immunity Threshold</li><li>\u2022 Herd Immunity Threshold</li><li>\u2022 Virologists have found that when a certain percentage of a population is vaccinated , the spread of the disease is effectively stopped ;</li><li>\u2022 Virologists</li><li>\u2022 certain percentage</li><li>\u2022 population</li><li>\u2022 vaccinated</li><li>\u2022 spread</li><li>\u2022 disease</li><li>\u2022 effectively stopped</li><li>\u2022 This critical percentage (HIT) depends on the disease and the vaccine:</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Herd immunity is effective in controlling diseases spread from person to person like Diptheria, polio, measles , but it does not apply to disease such as tetanus , where infection occurs through environmental exposure .</li><li>\u27a4 Herd immunity</li><li>\u27a4 controlling diseases</li><li>\u27a4 person to person</li><li>\u27a4 Diptheria, polio, measles</li><li>\u27a4 does not</li><li>\u27a4 tetanus</li><li>\u27a4 infection</li><li>\u27a4 environmental exposure</li><li>\u27a4 Ref: Park 26 th ed pg 111</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 111</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "7afb351c",
      "audio": ""
    },
    {
      "text": "A 39-year-old woman visits your clinic for pre-travel health advice. She is planning a humanitarian mission to a rural area in Africa and is seeking guidance on necessary immunizations. During the consultation, you evaluate her health history and current medical status to determine the suitability of live vaccines for her. Given her specific health profile, you need to identify which aspect of her medical history does NOT constitute a contraindication to receiving live vaccines. This particular attribute, despite being a part of her health background, does not automatically disqualify her from receiving live vaccines.",
      "options": [
        {
          "label": "A",
          "text": "Recent initiation of chemotherapy for breast cancer",
          "correct": false
        },
        {
          "label": "B",
          "text": "Systemic lupus erythematosus (SLE) under immunosuppressive therapy",
          "correct": false
        },
        {
          "label": "C",
          "text": "Asymptomatic HIV Infection",
          "correct": true
        },
        {
          "label": "D",
          "text": "Current pregnancy",
          "correct": false
        }
      ],
      "correct_answer": "C. Asymptomatic HIV Infection",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. \u00a0Asymptomatic HIV infection</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Recent initiation of chemotherapy for breast cancer:  Immunosuppression is the contraindication for live vaccine .</li><li>\u2022 Option A. Recent initiation of chemotherapy for breast cancer:  Immunosuppression</li><li>\u2022 contraindication</li><li>\u2022 live vaccine</li><li>\u2022 Option B. Systemic lupus erythematosus (SLE) under immunosuppressive therapy: Patients on immunosuppressive therapy, such as those with SLE, are generally advised against live vaccines due to the heightened risk of vaccine-induced disease .</li><li>\u2022 Option B. Systemic lupus erythematosus (SLE) under immunosuppressive therapy:</li><li>\u2022 advised</li><li>\u2022 live vaccines</li><li>\u2022 heightened risk</li><li>\u2022 vaccine-induced disease</li><li>\u2022 Option D. Current pregnancy: All live vaccines are contraindicated in Pregnancy EXCEPT Yellow fever vaccine</li><li>\u2022 Option D. Current pregnancy:</li><li>\u2022 All live vaccines</li><li>\u2022 contraindicated</li><li>\u2022 Pregnancy</li><li>\u2022 EXCEPT Yellow fever vaccine</li><li>\u2022 Some important pointers related to Vaccine Contraindication s -</li><li>\u2022 Vaccine Contraindication</li><li>\u2022 Vaccines contraindicated in Pregnancy : All live vaccines EXCEPT Yellow fever vaccine Vaccines contraindicated in Immuno-suppression : All live vaccines Vaccines contraindicated in Corticosteroid therapy : All live vaccines Vaccines contraindicated in fever : Typhoid vaccines (Typhoral; Typhim \u2013 Vi; TAB) Vaccines contraindicated in ARTI/diarrhoea : NONE Vaccines contraindicated together : Yellow fever and Cholera vaccine Vaccine contraindicated in Preterm-premature baby with birth weight < 2 kg : Hepatitis B Vaccines contraindicated in age < 1 year (infants): Yellow fever vaccine; Meningococcal vaccine and Pneumococcal vaccine Vaccines contraindicated in age < 2 years : Meningococcal vaccine; Pneumococcal vaccine and Typhoid vaccines Vaccine contraindicated in progressive neurological disease : Pertussis vaccine (Pertussis vaccine is not contraindicated in epilepsy controlled on medications, Cerebral palsy). Only absolute contraindication to killed vaccines : Severe local or general reaction to a previous dose.</li><li>\u2022 Vaccines contraindicated in Pregnancy : All live vaccines EXCEPT Yellow fever vaccine</li><li>\u2022 Pregnancy</li><li>\u2022 EXCEPT Yellow fever vaccine</li><li>\u2022 Vaccines contraindicated in Immuno-suppression : All live vaccines</li><li>\u2022 Immuno-suppression</li><li>\u2022 All live vaccines</li><li>\u2022 Vaccines contraindicated in Corticosteroid therapy : All live vaccines</li><li>\u2022 in Corticosteroid therapy</li><li>\u2022 All live vaccines</li><li>\u2022 Vaccines contraindicated in fever : Typhoid vaccines (Typhoral; Typhim \u2013 Vi; TAB)</li><li>\u2022 fever</li><li>\u2022 Typhoid vaccines</li><li>\u2022 Vaccines contraindicated in ARTI/diarrhoea : NONE</li><li>\u2022 in ARTI/diarrhoea</li><li>\u2022 NONE</li><li>\u2022 Vaccines contraindicated together : Yellow fever and Cholera vaccine</li><li>\u2022 contraindicated together</li><li>\u2022 Yellow fever and Cholera vaccine</li><li>\u2022 Vaccine contraindicated in Preterm-premature baby with birth weight < 2 kg : Hepatitis B</li><li>\u2022 Preterm-premature baby</li><li>\u2022 with birth weight < 2 kg</li><li>\u2022 Hepatitis B</li><li>\u2022 Vaccines contraindicated in age < 1 year (infants): Yellow fever vaccine; Meningococcal vaccine and Pneumococcal vaccine</li><li>\u2022 age < 1 year (infants):</li><li>\u2022 Yellow fever vaccine; Meningococcal vaccine and Pneumococcal vaccine</li><li>\u2022 Vaccines contraindicated in age < 2 years : Meningococcal vaccine; Pneumococcal vaccine and Typhoid vaccines</li><li>\u2022 age < 2 years</li><li>\u2022 Meningococcal vaccine; Pneumococcal vaccine and Typhoid vaccines</li><li>\u2022 Vaccine contraindicated in progressive neurological disease : Pertussis vaccine (Pertussis vaccine is not contraindicated in epilepsy controlled on medications, Cerebral palsy).</li><li>\u2022 progressive neurological disease</li><li>\u2022 Pertussis vaccine</li><li>\u2022 Only absolute contraindication to killed vaccines : Severe local or general reaction to a previous dose.</li><li>\u2022 absolute contraindication to killed vaccines</li><li>\u2022 Severe</li><li>\u2022 general reaction</li><li>\u2022 previous dose.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Live vaccines should not be administered to persons with immune deficiency diseases or to persons whose immune response may be suppressed because of leukaemia, lymphoma or malignancy or because of therapy with corticosteroids, alkylating agents, antimetabolic agents, or radiation, Pregnancy.</li><li>\u27a4 Live vaccines</li><li>\u27a4 not</li><li>\u27a4 immune deficiency diseases</li><li>\u27a4 immune response</li><li>\u27a4 suppressed</li><li>\u27a4 leukaemia, lymphoma</li><li>\u27a4 malignancy</li><li>\u27a4 corticosteroids, alkylating agents, antimetabolic agents, or radiation, Pregnancy.</li><li>\u27a4 Ref: Park 26 th ed pg 111.</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 111.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a7c65aa2",
      "audio": ""
    },
    {
      "text": "During a practical examination, you encounter a question related to vaccine types. You are presented with a set of vaccines and asked to identify which one is NOT a live attenuated vaccine. Live attenuated vaccines are made from a weakened form of the virus or bacteria, but one of the vaccines listed is prepared differently. Based on its method of preparation, which of the following vaccines is not a live attenuated vaccine?",
      "options": [
        {
          "label": "A",
          "text": "Sabin",
          "correct": false
        },
        {
          "label": "B",
          "text": "Rotavirus",
          "correct": false
        },
        {
          "label": "C",
          "text": "17-D",
          "correct": false
        },
        {
          "label": "D",
          "text": "Rabies",
          "correct": true
        }
      ],
      "correct_answer": "D. Rabies",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/23/screenshot-2023-08-11-1921039026_SBEBAIV.jpg"
      ],
      "explanation": "<p><strong>Ans. D. Rabies</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Sabin: Live attenuated Oral Polio Vaccine</li><li>\u2022 Option A. Sabin:</li><li>\u2022 Live attenuated Oral Polio Vaccine</li><li>\u2022 Option B. Rota virus: Live attenuated oral vaccine</li><li>\u2022 Option B. Rota virus: Live attenuated oral vaccine</li><li>\u2022 Option C. 17 D - Live attenuated , lyophilized (Freeze dried) Yellow fever vaccine</li><li>\u2022 Option C. 17 D</li><li>\u2022 Live attenuated</li><li>\u2022 lyophilized</li><li>\u2022 Yellow fever vaccine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Park 26 th ed pg 111.</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 111.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b10f90c2",
      "audio": ""
    },
    {
      "text": "A 14-week-old infant is brought to a Primary Health Center for routine immunizations. During this visit, she receives all her scheduled vaccines, but the Rota Virus Vaccine (RVV) is unavailable due to a shortage. As a result, she misses her third dose of RVV and is advised to return when it's available. For optimal immunization scheduling, it's important to know the minimum recommended interval between the administration of the RVV and other vaccines if they are not given on the same day. What is this minimum recommended interval before administering the RVV, following the administration of other vaccines?",
      "options": [
        {
          "label": "A",
          "text": "1 day",
          "correct": false
        },
        {
          "label": "B",
          "text": "1 week",
          "correct": false
        },
        {
          "label": "C",
          "text": "3 weeks",
          "correct": true
        },
        {
          "label": "D",
          "text": "4 weeks",
          "correct": false
        }
      ],
      "correct_answer": "C. 3 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. 3 weeks</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 General rules for multiple vaccine administration :</li><li>\u2022 rules</li><li>\u2022 multiple vaccine administration</li><li>\u2022 2 live vaccines can be given together Live and killed vaccines can be given together Live vaccine should not be administered to immuno-deficient or immunosuppressed persons 2 live vaccines can be administered simultaneously at different sites (or at an interval of 3 weeks) Cholera vaccine and Yellow fever vaccine cannot be given together OPV is the only live vaccine where a single dose is not sufficient for immunization</li><li>\u2022 2 live vaccines can be given together</li><li>\u2022 2 live vaccines</li><li>\u2022 together</li><li>\u2022 Live and killed vaccines can be given together</li><li>\u2022 Live and killed vaccines</li><li>\u2022 together</li><li>\u2022 Live vaccine should not be administered to immuno-deficient or immunosuppressed persons</li><li>\u2022 Live vaccine</li><li>\u2022 not</li><li>\u2022 immuno-deficient or immunosuppressed</li><li>\u2022 2 live vaccines can be administered simultaneously at different sites (or at an interval of 3 weeks)</li><li>\u2022 2 live vaccines</li><li>\u2022 at different sites</li><li>\u2022 Cholera vaccine and Yellow fever vaccine cannot be given together</li><li>\u2022 Cholera vaccine and Yellow fever vaccine</li><li>\u2022 cannot</li><li>\u2022 together</li><li>\u2022 OPV is the only live vaccine where a single dose is not sufficient for immunization</li><li>\u2022 OPV</li><li>\u2022 only live vaccine</li><li>\u2022 single dose</li><li>\u2022 not sufficient</li><li>\u2022 immunization</li><li>\u2022 Rules for Live Vaccine and Immunoglobulin :</li><li>\u2022 Rules</li><li>\u2022 Live Vaccine and Immunoglobulin</li><li>\u2022 Live vaccines should not normally be given for 12 weeks after an injection of normal human Ig If a live vaccine has already been given, NHIg injection should be deferred for 2 weeks</li><li>\u2022 Live vaccines should not normally be given for 12 weeks after an injection of normal human Ig</li><li>\u2022 Live vaccines</li><li>\u2022 not</li><li>\u2022 12 weeks</li><li>\u2022 after</li><li>\u2022 normal human Ig</li><li>\u2022 If a live vaccine has already been given, NHIg injection should be deferred for 2 weeks</li><li>\u2022 live vaccine</li><li>\u2022 given,</li><li>\u2022 NHIg</li><li>\u2022 deferred</li><li>\u2022 2 weeks</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Two live vaccines can be administered simultaneously at different sites (or at an interval of 3 weeks )</li><li>\u27a4 Two live vaccines</li><li>\u27a4 administered</li><li>\u27a4 at different sites</li><li>\u27a4 interval</li><li>\u27a4 3 weeks</li><li>\u27a4 Ref : Park 26 th ed pg 111.</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26 th ed pg 111.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "357f8402",
      "audio": ""
    },
    {
      "text": "A Community Medicine SR is conducting a session with medical students on vaccine formulations and their components. During the session, the topic shifts to the use of adjuvants in vaccines and their specific roles. The pediatrician highlights the Diphtheria, Tetanus, and Pertussis (DTaP) vaccine, pointing out that it contains aluminum phosphate. The students are then asked to consider why aluminum phosphate is included in this vaccine. What is the primary role of aluminum phosphate in the DTaP vaccine?",
      "options": [
        {
          "label": "A",
          "text": "Detoxifies the micro organisms",
          "correct": false
        },
        {
          "label": "B",
          "text": "Stabilizes the antigen",
          "correct": false
        },
        {
          "label": "C",
          "text": "Enhances the immune response",
          "correct": true
        },
        {
          "label": "D",
          "text": "Preservatives",
          "correct": false
        }
      ],
      "correct_answer": "C. Enhances the immune response",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Enhances the immune response</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Detoxifies the microorganisms : Preservatives are used to detoxify the microorganisms. Antibiotics are used during the manufacturing phase to prevent bacterial contamination of the tissue culture cells in which the viruses are grown .</li><li>\u2022 Option A. Detoxifies the microorganisms</li><li>\u2022 Preservatives</li><li>\u2022 detoxify</li><li>\u2022 microorganisms.</li><li>\u2022 Antibiotics</li><li>\u2022 used</li><li>\u2022 prevent bacterial contamination</li><li>\u2022 tissue culture cells</li><li>\u2022 viruses are grown</li><li>\u2022 Option B . Stabilizes the antigen: Stabilizers acts by controlling acidity (pH); stabilizing antigens through necessary steps in the manufacturing process, such as freeze drying ; and preventing antigens from adhering to the sides of glass vials with a resultant loss in immunogenicity .</li><li>\u2022 Option B</li><li>\u2022 Stabilizes the antigen:</li><li>\u2022 Stabilizers</li><li>\u2022 acidity (pH); stabilizing antigens</li><li>\u2022 freeze drying</li><li>\u2022 preventing antigens</li><li>\u2022 adhering</li><li>\u2022 glass vials</li><li>\u2022 resultant loss</li><li>\u2022 immunogenicity</li><li>\u2022 Examples - potassium or sodium salts, lactose, human serum albumin and a variety of animal proteins, such as gelatin and bovine serum albumin.</li><li>\u2022 potassium or sodium salts, lactose, human serum albumin</li><li>\u2022 gelatin</li><li>\u2022 bovine serum albumin.</li><li>\u2022 Option D. Preservatives: These are the chemicals (e.g. thiomersal, formaldehyde ) added to killed or subunit vaccines in order to inactivate viruses , detoxify bacterial toxins , and to prevent serious secondary infections as a result of bacterial or fungal contamination.</li><li>\u2022 Option D. Preservatives:</li><li>\u2022 thiomersal, formaldehyde</li><li>\u2022 killed or subunit vaccines</li><li>\u2022 inactivate viruses</li><li>\u2022 detoxify bacterial toxins</li><li>\u2022 prevent</li><li>\u2022 secondary</li><li>\u2022 infections</li><li>\u2022 bacterial or fungal contamination.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The role of adjuvants like aluminum phosphate in vaccines, which is to enhance the immune response to the antigen , as seen in the Diphtheria vaccine.</li><li>\u27a4 role of adjuvants</li><li>\u27a4 aluminum phosphate</li><li>\u27a4 enhance</li><li>\u27a4 immune response</li><li>\u27a4 antigen</li><li>\u27a4 Diphtheria vaccine.</li><li>\u27a4 Ref: Park 26 th ed pg 114</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 114</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "3af75fba",
      "audio": ""
    },
    {
      "text": "In a seminar on immunoglobulin therapy, a discussion arises about the World Health Organization (WHO) standards for Normal Human Immunoglobulin (NHIG) preparation. The speaker presents various criteria that define these standards and asks the audience to identify which of the given options is NOT included in the WHO standards for NHIG. This question aims to highlight a specific aspect of NHIG preparation that does not align with WHO guidelines.",
      "options": [
        {
          "label": "A",
          "text": "90% should be Ig G",
          "correct": false
        },
        {
          "label": "B",
          "text": "All IgG subclass should be present",
          "correct": false
        },
        {
          "label": "C",
          "text": "Should contain high concentration of Ig A",
          "correct": true
        },
        {
          "label": "D",
          "text": "Should contain antibody against at least 2 bacterial and viral species",
          "correct": false
        }
      ],
      "correct_answer": "C. Should contain high concentration of Ig A",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Should contain high concentration of IgA</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. 90% should be Ig G : Correct. This ensures the primary immunoglobulin in NHIG is IgG , known for its antibody activity against pathogens.</li><li>\u2022 Option A. 90% should be Ig G</li><li>\u2022 primary immunoglobulin</li><li>\u2022 NHIG</li><li>\u2022 IgG</li><li>\u2022 antibody</li><li>\u2022 activity against pathogens.</li><li>\u2022 Option B. All IgG subclass should be present : Correct. This is to maintain a broad spectrum of antibody activity .</li><li>\u2022 Option B. All IgG subclass should be present</li><li>\u2022 broad spectrum of antibody activity</li><li>\u2022 Option D. Should contain antibody against atleast 2 bacterial and viral species : Correct. This criterion ensures the NHIG is effective against a range of pathogens.</li><li>\u2022 Option D. Should contain antibody against atleast 2 bacterial and viral species</li><li>\u2022 ensures</li><li>\u2022 NHIG</li><li>\u2022 effective against</li><li>\u2022 range of pathogens.</li><li>\u2022 The Normal Human Immunoglobulin preparation should contain:</li><li>\u2022 Normal Human Immunoglobulin</li><li>\u2022 contain:</li><li>\u2022 At least 90 percent intact IgG It should be as free as possible from IgG aggregates All IgG sub-classes should be present There should be a low IgA concentration The level of antibody against at least two bacterial species and two viruses should be ascertained etc</li><li>\u2022 At least 90 percent intact IgG</li><li>\u2022 90 percent</li><li>\u2022 IgG</li><li>\u2022 It should be as free as possible from IgG aggregates</li><li>\u2022 free</li><li>\u2022 IgG aggregates</li><li>\u2022 All IgG sub-classes should be present</li><li>\u2022 IgG sub-classes</li><li>\u2022 present</li><li>\u2022 There should be a low IgA concentration</li><li>\u2022 low IgA concentration</li><li>\u2022 The level of antibody against at least two bacterial species and two viruses should be ascertained etc</li><li>\u2022 level of</li><li>\u2022 antibody against</li><li>\u2022 two bacterial species</li><li>\u2022 two viruses</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 WHO standards for Normal Human Immunoglobulin preparation , focus on the predominance of IgG (90%) and the presence of all IgG subclasses , and low concentration of IgA</li><li>\u27a4 WHO standards</li><li>\u27a4 Normal Human Immunoglobulin preparation</li><li>\u27a4 predominance</li><li>\u27a4 IgG (90%)</li><li>\u27a4 all IgG subclasses</li><li>\u27a4 low concentration</li><li>\u27a4 IgA</li><li>\u27a4 Ref : Park 26 th ed pg 115</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26 th ed pg 115</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0505234c",
      "audio": ""
    },
    {
      "text": "In a clinical immunology lecture, the topic of interaction between live vaccines and Normal Human Immunoglobulin (NHIG) administration is discussed. The lecturer emphasizes the importance of timing when administering NHIG after a live vaccine to avoid diminishing the vaccine's efficacy. The students are then asked to determine the recommended minimum interval that should elapse after administering a live vaccine before NHIG can be safely given. This interval is crucial to ensure that the live vaccine has sufficient time to elicit an effective immune response before NHIG is introduced.",
      "options": [
        {
          "label": "A",
          "text": "2 weeks",
          "correct": true
        },
        {
          "label": "B",
          "text": "4 weeks",
          "correct": false
        },
        {
          "label": "C",
          "text": "6 weeks",
          "correct": false
        },
        {
          "label": "D",
          "text": "12 weeks",
          "correct": false
        }
      ],
      "correct_answer": "A. 2 weeks",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. A. 2 weeks</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Live vaccines should not normally be given for 12 weeks after an injection of normal human Ig , and if a live vaccine has already been given, NHIg injection should be deferred for 2 weeks as this may jeopardize the immune response to the vaccine .</li><li>\u27a4 Live vaccines</li><li>\u27a4 not</li><li>\u27a4 12 weeks</li><li>\u27a4 normal human Ig</li><li>\u27a4 live vaccine</li><li>\u27a4 NHIg</li><li>\u27a4 deferred</li><li>\u27a4 2 weeks</li><li>\u27a4 jeopardize</li><li>\u27a4 immune response</li><li>\u27a4 vaccine</li><li>\u27a4 Ref : Park 26 th ed pg 115</li><li>\u27a4 Ref</li><li>\u27a4 : Park 26 th ed pg 115</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "1009746d",
      "audio": ""
    },
    {
      "text": "In a medical training session about the BCG vaccine, used for tuberculosis prevention, specific details regarding its preparation and administration are being discussed. The trainees are presented with various statements about the BCG vaccine and asked to identify which one is true. This question is designed to test their knowledge about the practical aspects of handling and administering the BCG vaccine.",
      "options": [
        {
          "label": "A",
          "text": "\u200b\u200b\u200b\u200b\u200b\u200b Distilled water is used as diluent for BCG vaccine",
          "correct": false
        },
        {
          "label": "B",
          "text": "The site for injection should be cleaned thoroughly with spirit",
          "correct": false
        },
        {
          "label": "C",
          "text": "Mantoux test becomes positive after 48 hours of vaccination",
          "correct": false
        },
        {
          "label": "D",
          "text": "WHO recommends Danish 1331 strain for vaccine production",
          "correct": true
        }
      ],
      "correct_answer": "D. WHO recommends Danish 1331 strain for vaccine production",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. D. WHO recommends Danish 1331 strain for vaccine production</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Distilled water is used as a diluent for the BCG vaccine: Incorrect. BCG is a lyophilized (freeze dried) vaccine and is reconstituted with Normal Saline as diluent and must be used within 1 hour of reconstitution</li><li>\u2022 Option A. Distilled water is used as a diluent for the BCG vaccine:</li><li>\u2022 lyophilized (freeze dried) vaccine</li><li>\u2022 reconstituted</li><li>\u2022 Normal Saline</li><li>\u2022 diluent</li><li>\u2022 used</li><li>\u2022 1 hour of reconstitution</li><li>\u2022 Option B. The site for injection should be cleaned thoroughly with spirit: Incorrect. Cleaning the injection site with spirit or alcohol- based solutions is actually not recommended for the BCG vaccine , as it can kill the live bacteria in the vaccine.</li><li>\u2022 Option B. The site for injection should be cleaned thoroughly with spirit:</li><li>\u2022 Cleaning</li><li>\u2022 injection site</li><li>\u2022 spirit or alcohol-</li><li>\u2022 not</li><li>\u2022 BCG vaccine</li><li>\u2022 kill the live bacteria</li><li>\u2022 vaccine.</li><li>\u2022 Option C. The Mantoux test becomes positive after 48 hours of vaccination :  Incorrect. The test does not become positive immediately after BCG vaccination . It takes 8\u201314 weeks to become positive after vaccination .</li><li>\u2022 Option C. The Mantoux test becomes positive after 48 hours of vaccination</li><li>\u2022 does not</li><li>\u2022 positive</li><li>\u2022 immediately</li><li>\u2022 BCG vaccination</li><li>\u2022 8\u201314 weeks</li><li>\u2022 positive</li><li>\u2022 vaccination</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 WHO recommended the Danish 1331 strain for BCG vaccine production, sterile saline is used as a diluent and Mantoux test takes 8\u201314 weeks to become positive after vaccination.</li><li>\u27a4 WHO</li><li>\u27a4 Danish 1331 strain</li><li>\u27a4 BCG vaccine</li><li>\u27a4 sterile saline</li><li>\u27a4 diluent</li><li>\u27a4 Mantoux test</li><li>\u27a4 8\u201314 weeks</li><li>\u27a4 positive</li><li>\u27a4 after vaccination.</li><li>\u27a4 Ref: Park 27/e p231</li><li>\u27a4 Ref:</li><li>\u27a4 Park 27/e p231</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "60625b5f",
      "audio": ""
    },
    {
      "text": "Mrs. X, an Auxiliary Nurse Midwife (ANM), is conducting an immunization session at her sub-centre. She has vaccinated three children with the MR (Measles-Rubella) vaccine from a 5-dose vial. After completing this session, she moves to the next village, where she needs to vaccinate one more child with the MR vaccine. Considering best practices in vaccine administration and safety, what should Mrs. X do with the opened MR vaccine vial to vaccinate the child in the new area?",
      "options": [
        {
          "label": "A",
          "text": "Use the same vial if not exceeded 4 hours from opening of vial",
          "correct": false
        },
        {
          "label": "B",
          "text": "If exceeded 4 hrs check for VVM, if VVM is there use the same vial",
          "correct": false
        },
        {
          "label": "C",
          "text": "Discard the old opened vial and use new vial",
          "correct": true
        },
        {
          "label": "D",
          "text": "Consult the medical officer",
          "correct": false
        }
      ],
      "correct_answer": "C. Discard the old opened vial and use new vial",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C. Discard the old opened vial and use new vial</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Use the same vial if not exceeded 4 hours from the opening of the vial: As there is change of location, so new vial for vaccinating the child in the new area . This practice ensures the potency and safety of the vaccine , adhering to strict vaccine handling and administration guidelines.</li><li>\u2022 Option A. Use the same vial if not exceeded 4 hours from the opening of the vial:</li><li>\u2022 new vial</li><li>\u2022 vaccinating</li><li>\u2022 new area</li><li>\u2022 ensures</li><li>\u2022 potency</li><li>\u2022 safety</li><li>\u2022 vaccine</li><li>\u2022 adhering</li><li>\u2022 strict vaccine handling</li><li>\u2022 administration guidelines.</li><li>\u2022 Option B. If exceeded 4 hours, check for VVM (Vaccine Vial Monitor): if it shows viability, use the same vial . Incorrect.</li><li>\u2022 Option B. If exceeded 4 hours, check for VVM (Vaccine Vial Monitor):</li><li>\u2022 viability,</li><li>\u2022 same vial</li><li>\u2022 Incorrect.</li><li>\u2022 Option D. Consult the medical officer: While consulting a medical officer is a good practice in uncertain situations, in this case, the standard protocol is to use a new vial .</li><li>\u2022 Option D. Consult the medical officer:</li><li>\u2022 consulting</li><li>\u2022 medical officer</li><li>\u2022 good practice</li><li>\u2022 uncertain</li><li>\u2022 standard protocol</li><li>\u2022 use</li><li>\u2022 new vial</li><li>\u2022 Open Vial Policy 2015</li><li>\u2022 Open Vial Policy 2015</li><li>\u2022 Not applicable for Vaccines : Measles, BCG, JE Applicable for Vaccines: OPV, DPT, Hepatitis B, TT, Liquid Pentavalent - Opened vaccine vials can be used in subsequent session \u2018 up to 4 weeks\u2019 .</li><li>\u2022 Not applicable for Vaccines : Measles, BCG, JE</li><li>\u2022 Not</li><li>\u2022 Vaccines</li><li>\u2022 Measles, BCG, JE</li><li>\u2022 Applicable for Vaccines: OPV, DPT, Hepatitis B, TT, Liquid Pentavalent - Opened vaccine vials can be used in subsequent session \u2018 up to 4 weeks\u2019 .</li><li>\u2022 Applicable</li><li>\u2022 OPV, DPT, Hepatitis B, TT, Liquid Pentavalent -</li><li>\u2022 used</li><li>\u2022 subsequent session</li><li>\u2022 \u2018</li><li>\u2022 4 weeks\u2019</li><li>\u2022 The expiry date should not pass, VVM within usability limits , Cold chain maintenance. Vaccine vial septum not submerged in water or contaminated , Aseptic technique used to withdraw doses . Record date and time of each vial opening.</li><li>\u2022 expiry date</li><li>\u2022 not</li><li>\u2022 VVM</li><li>\u2022 usability limits</li><li>\u2022 Cold chain</li><li>\u2022 Vaccine vial septum</li><li>\u2022 water</li><li>\u2022 contaminated</li><li>\u2022 Aseptic</li><li>\u2022 withdraw doses</li><li>\u2022 Record date</li><li>\u2022 time</li><li>\u2022 each vial opening.</li><li>\u2022 At end of session return all open vials to Cold chain - Reusable open vials : DPT, DT, Hepatitis B, Pentavalent Non-reusable open vials : Measles, BCG, JE ( Destroy after 48 hours or Next session whichever earlier ) If any AEFI reported: Store all vials in Cold chain till completion of investigation</li><li>\u2022 At end of session return all open vials to Cold chain - Reusable open vials : DPT, DT, Hepatitis B, Pentavalent Non-reusable open vials : Measles, BCG, JE ( Destroy after 48 hours or Next session whichever earlier ) If any AEFI reported: Store all vials in Cold chain till completion of investigation</li><li>\u2022 end of session</li><li>\u2022 all open vials</li><li>\u2022 Cold chain</li><li>\u2022 Reusable open vials : DPT, DT, Hepatitis B, Pentavalent Non-reusable open vials : Measles, BCG, JE ( Destroy after 48 hours or Next session whichever earlier ) If any AEFI reported: Store all vials in Cold chain till completion of investigation</li><li>\u2022 Reusable open vials : DPT, DT, Hepatitis B, Pentavalent</li><li>\u2022 Reusable open vials</li><li>\u2022 DPT, DT, Hepatitis B, Pentavalent</li><li>\u2022 Non-reusable open vials : Measles, BCG, JE ( Destroy after 48 hours or Next session whichever earlier )</li><li>\u2022 Non-reusable</li><li>\u2022 open vials</li><li>\u2022 Measles, BCG, JE</li><li>\u2022 Destroy after 48 hours</li><li>\u2022 Next session</li><li>\u2022 earlier</li><li>\u2022 If any AEFI reported: Store all vials in Cold chain till completion of investigation</li><li>\u2022 AEFI</li><li>\u2022 Store all vials</li><li>\u2022 Cold chain</li><li>\u2022 completion</li><li>\u2022 investigation</li><li>\u2022 RECENT UPDATE \u2013 Rotavirus vaccine is under Open Vial Policy .</li><li>\u2022 RECENT UPDATE</li><li>\u2022 Rotavirus vaccine</li><li>\u2022 Open Vial Policy</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vaccines like OPV, DPT, Hepatitis B, TT, Liquid Pentavalent, rota virus follow the Open vial policy , these can be used in subsequent sessions \u2018up to 4 weeks\u2019 . Open Vial Policy does not apply to Measles, BCG and Japanese Encephalitis (JE) vaccines.</li><li>\u27a4 OPV, DPT, Hepatitis B, TT, Liquid Pentavalent, rota virus</li><li>\u27a4 Open vial policy</li><li>\u27a4 used</li><li>\u27a4 subsequent sessions</li><li>\u27a4 4 weeks\u2019</li><li>\u27a4 Open Vial Policy</li><li>\u27a4 not</li><li>\u27a4 to Measles, BCG and Japanese Encephalitis (JE) vaccines.</li><li>\u27a4 Ref: Park 26 th ed pg 117</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 117</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a3127517",
      "audio": ""
    },
    {
      "text": "As the Medical Officer overseeing a primary health center, one of your responsibilities is to ensure the correct storage of vaccines. Proper storage is crucial for maintaining vaccine efficacy, particularly regarding their sensitivity to freezing temperatures. Among the vaccines commonly stored at your facility, you need to identify which one is most sensitive to freezing and requires the most careful temperature management to retain its effectiveness. Which of the following vaccines is known to be the most freeze-sensitive?",
      "options": [
        {
          "label": "A",
          "text": "OPV",
          "correct": false
        },
        {
          "label": "B",
          "text": "DPT",
          "correct": false
        },
        {
          "label": "C",
          "text": "IPV",
          "correct": false
        },
        {
          "label": "D",
          "text": "Hepatitis B",
          "correct": true
        }
      ],
      "correct_answer": "D. Hepatitis B",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/image-20230710163422-1.png"
      ],
      "explanation": "<p><strong>Ans. D. Hepatitis B</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. OPV: More sensitive to heat . OPV is stored at +2\u00b0 to +8\u00b0C. Except for long-term storage when it\u2019s kept in a freezer (-15\u00b0 to -25\u00b0C)</li><li>\u2022 Option A. OPV:</li><li>\u2022 sensitive</li><li>\u2022 heat</li><li>\u2022 OPV</li><li>\u2022 +2\u00b0 to +8\u00b0C.</li><li>\u2022 long-term storage</li><li>\u2022 kept</li><li>\u2022 freezer (-15\u00b0 to -25\u00b0C)</li><li>\u2022 Option B. DPT: Stored at +2\u00b0 to +8\u00b0C . Both heat and cold sensitive but its sensitivity to freezing is not as critical as that of the Hepatitis B vaccine.</li><li>\u2022 Option B. DPT:</li><li>\u2022 Stored</li><li>\u2022 +2\u00b0 to +8\u00b0C</li><li>\u2022 heat and cold sensitive</li><li>\u2022 its sensitivity</li><li>\u2022 freezing</li><li>\u2022 not</li><li>\u2022 Hepatitis B vaccine.</li><li>\u2022 Option C. IPV: Stored at +2\u00b0 to +8\u00b0C .  Both heat and cold sensitive but its sensitivity to freezing is not as critical as that of the Hepatitis B vaccine.</li><li>\u2022 Option C. IPV:</li><li>\u2022 +2\u00b0 to +8\u00b0C</li><li>\u2022 heat and cold sensitive</li><li>\u2022 its sensitivity</li><li>\u2022 freezing</li><li>\u2022 not</li><li>\u2022 Hepatitis B vaccine.</li><li>\u2022 Note:</li><li>\u2022 Note:</li><li>\u2022 Under NIS, RCH Program all vaccines are stored in +2\u00b0 to +8\u00b0C. SHAKE TEST is used to check if freeze-sensitive vaccines have been damaged by exposure to freezing temperatures below 0 degrees C; after the test , the previously frozen vaccine shows flakes . Most Thermolabile vaccine : Reconstituted BCG Most Thermostable vaccine : TT</li><li>\u2022 Under NIS, RCH Program all vaccines are stored in +2\u00b0 to +8\u00b0C.</li><li>\u2022 NIS, RCH</li><li>\u2022 all vaccines</li><li>\u2022 stored</li><li>\u2022 +2\u00b0 to +8\u00b0C.</li><li>\u2022 SHAKE TEST is used to check if freeze-sensitive vaccines have been damaged by exposure to freezing temperatures below 0 degrees C; after the test , the previously frozen vaccine shows flakes .</li><li>\u2022 SHAKE TEST</li><li>\u2022 freeze-sensitive vaccines</li><li>\u2022 damaged</li><li>\u2022 exposure</li><li>\u2022 below</li><li>\u2022 0 degrees</li><li>\u2022 after</li><li>\u2022 test</li><li>\u2022 frozen</li><li>\u2022 shows flakes</li><li>\u2022 Most Thermolabile vaccine : Reconstituted BCG</li><li>\u2022 Thermolabile vaccine</li><li>\u2022 Reconstituted BCG</li><li>\u2022 Most Thermostable vaccine : TT</li><li>\u2022 Thermostable vaccine</li><li>\u2022 TT</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref : Immunization handbook for health workers, 2018, MoHFW, GoI, pg 69.</li><li>\u27a4 Ref</li><li>\u27a4 : Immunization handbook for health workers, 2018, MoHFW, GoI, pg 69.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "fb94f165",
      "audio": ""
    },
    {
      "text": "During a training session on vaccine management and storage, the topic of the Open Vial Policy (OVP) is discussed. OVP permits the use of certain multi-dose vaccine vials in subsequent immunization sessions even after the vial has been opened, as long as specific conditions are met. This policy is crucial for efficient vaccine utilization, especially in resource-limited settings. The trainees are asked to identify which of the following vaccines is NOT included under the Open Vial Policy, meaning it should not be used in subsequent sessions once the vial has been opened.",
      "options": [
        {
          "label": "A",
          "text": "Pentavalent",
          "correct": false
        },
        {
          "label": "B",
          "text": "IPV",
          "correct": false
        },
        {
          "label": "C",
          "text": "JE",
          "correct": true
        },
        {
          "label": "D",
          "text": "OPV",
          "correct": false
        }
      ],
      "correct_answer": "C. JE",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) JE</strong></p>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Open vial policy \u2013 for Hep B, OPV, DPT, pentavalent, TT, PCV, IPV, Rotavirus vaccines</li><li>\u27a4 Open vial policy</li><li>\u27a4 Hep B, OPV, DPT, pentavalent, TT, PCV, IPV, Rotavirus vaccines</li><li>\u27a4 No open vial policy for - BCG, MR, JE Vaccines</li><li>\u27a4 No open vial policy</li><li>\u27a4 BCG, MR, JE Vaccines</li><li>\u27a4 Ref: Immunization handbook for health workers, 2018, MoHFW, GoI, Pg, 67</li><li>\u27a4 Ref:</li><li>\u27a4 Immunization handbook for health workers, 2018, MoHFW, GoI, Pg, 67</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "51f10a9d",
      "audio": ""
    },
    {
      "text": "As part of a training session for new healthcare staff, you are emphasizing the critical aspect of vaccine storage and the significance of monitoring the condition of vaccine vials. An essential tool in this process is the Vaccine Vial Monitor (VVM). It's crucial for the staff to understand the function and importance of the VVM in ensuring vaccine potency. Which of the following statements accurately reflects the true purpose or function of the Vaccine Vial Monitor?",
      "options": [
        {
          "label": "A",
          "text": "The VVM number indicates the time in days that it takes for the inner square to reach the color indicating a discard point, if the vial is exposed to a constant temperature of 37-degree C.",
          "correct": false
        },
        {
          "label": "B",
          "text": "VVM is the marker of the cold chain maintenance and the potency of the vaccine",
          "correct": false
        },
        {
          "label": "C",
          "text": "The inner square is white and the outer circle is blue",
          "correct": false
        },
        {
          "label": "D",
          "text": "All the above",
          "correct": true
        }
      ],
      "correct_answer": "D. All the above",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/10/image-20230710180846-1.png"
      ],
      "explanation": "<p><strong>Ans. D) All the above</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 VVM is a marker of potency .</li><li>\u2022 VVM</li><li>\u2022 potency</li><li>\u2022 VVM indicates efficiency of cold chain (temperature maintenance)</li><li>\u2022 VVM</li><li>\u2022 efficiency</li><li>\u2022 cold chain</li><li>\u2022 VVM is a simple tool that enables vaccinator to know if the vaccine is potent at the time of administration .</li><li>\u2022 VVM</li><li>\u2022 enables vaccinator</li><li>\u2022 vaccine is potent</li><li>\u2022 administration</li><li>\u2022 VVM is a label containing a heat-sensitive material which is placed on a vaccine vial to register cumulative heat exposure over time . If the color of inner square is similar or darker than the outer circle , the vaccine vial should be discarded. (Only inner square changes colour , circle always remain blue )</li><li>\u2022 VVM</li><li>\u2022 heat-sensitive</li><li>\u2022 vaccine vial</li><li>\u2022 register</li><li>\u2022 heat exposure</li><li>\u2022 over time</li><li>\u2022 color</li><li>\u2022 inner square</li><li>\u2022 similar or darker</li><li>\u2022 outer circle</li><li>\u2022 vial</li><li>\u2022 discarded.</li><li>\u2022 inner square changes colour</li><li>\u2022 circle</li><li>\u2022 blue</li><li>\u2022 Mandatory since 1998 for quality assurance. This is an example of \" Appropriate Technology \".</li><li>\u2022 Mandatory</li><li>\u2022 1998</li><li>\u2022 Appropriate Technology</li><li>\u2022 WHO Grading of VVM (OPV) -</li><li>\u2022 WHO</li><li>\u2022 VVM (OPV)</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The purpose of the Vaccine Vial Monitor (VVM), which is to indicate a vaccine's exposure to heat and help in determining its viability based on cumulative heat exposure , rather than freezing conditions, expiration dates, or tampering .</li><li>\u27a4 Vaccine Vial Monitor (VVM),</li><li>\u27a4 indicate a vaccine's</li><li>\u27a4 heat</li><li>\u27a4 its viability</li><li>\u27a4 heat exposure</li><li>\u27a4 rather</li><li>\u27a4 freezing conditions, expiration dates,</li><li>\u27a4 tampering</li><li>\u27a4 Ref: Park 26 th ed pg 121, https://www.who.int/publications/m/item/vaccine-vial-</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 121, https://www.who.int/publications/m/item/vaccine-vial-</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "0bdc1791",
      "audio": ""
    },
    {
      "text": "In a workshop dedicated to vaccine storage and handling, the topic of the \"shake test\" is introduced. This test is a practical method used to determine if freeze-sensitive vaccines have been damaged due to freezing. The participants are presented with a list of vaccines and asked to identify for which vaccine the shake test is not applicable. This question aims to assess their understanding of the shake test and its relevance to different types of vaccines, especially in the context of freeze sensitivity.",
      "options": [
        {
          "label": "A",
          "text": "DPT",
          "correct": false
        },
        {
          "label": "B",
          "text": "IPV",
          "correct": true
        },
        {
          "label": "C",
          "text": "Hepatitis B",
          "correct": false
        },
        {
          "label": "D",
          "text": "Tetanus Toxoid",
          "correct": false
        }
      ],
      "correct_answer": "B. IPV",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/10/24/image_dfA9vwc.png"
      ],
      "explanation": "<p><strong>Ans. B) IPV</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Shake Test is not applicable for IPV.</li><li>\u2022 Shake Test</li><li>\u2022 not</li><li>\u2022 IPV.</li><li>\u2022 The Shake Test currently applies to freeze sensitive vaccines which are:</li><li>\u2022 Shake Test</li><li>\u2022 freeze sensitive vaccines</li><li>\u2022 DPT-Hep B-Hib TT PCV13 Hepatitis B HPV</li><li>\u2022 DPT-Hep B-Hib</li><li>\u2022 TT</li><li>\u2022 PCV13</li><li>\u2022 Hepatitis B</li><li>\u2022 HPV</li><li>\u2022 SHAKE TEST</li><li>\u2022 SHAKE TEST</li><li>\u2022 It is used to check if Freeze sensitive vaccines have been damaged by exposure to freezing temperatures below 0 degrees C ; after the test the previously Frozen vaccine shows flakes</li><li>\u2022 used</li><li>\u2022 Freeze sensitive vaccines</li><li>\u2022 damaged by exposure</li><li>\u2022 freezing temperatures</li><li>\u2022 below 0 degrees</li><li>\u2022 C</li><li>\u2022 previously Frozen vaccine</li><li>\u2022 flakes</li><li>\u2022 Interpretation:</li><li>\u2022 Interpretation:</li><li>\u2022 If SR in Test vial < Control vial: Vaccine had not been damaged If SR in Test vial > Control vial : Vaccine had been damaged , Do not use and Inform the supervisors</li><li>\u2022 If SR in Test vial < Control vial: Vaccine had not been damaged</li><li>\u2022 SR</li><li>\u2022 Test vial < Control vial:</li><li>\u2022 not</li><li>\u2022 damaged</li><li>\u2022 If SR in Test vial > Control vial : Vaccine had been damaged , Do not use and Inform the supervisors</li><li>\u2022 SR</li><li>\u2022 Test vial > Control vial</li><li>\u2022 damaged</li><li>\u2022 Do not use</li><li>\u2022 Inform</li><li>\u2022 supervisors</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 The Shake Test currently applies to freeze sensitive vaccines which are: DPT-Hep B-Hib; TT; PCV13; Hepatitis B; HPV . Shake Test is not applicable for IPV</li><li>\u27a4 Shake Test</li><li>\u27a4 freeze sensitive vaccines</li><li>\u27a4 DPT-Hep B-Hib; TT; PCV13; Hepatitis B; HPV</li><li>\u27a4 Shake Test</li><li>\u27a4 not</li><li>\u27a4 IPV</li><li>\u27a4 Ref: Park 27/e p123</li><li>\u27a4 Ref:</li><li>\u27a4 Park 27/e p123</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a6913b48",
      "audio": ""
    },
    {
      "text": "In a Primary Health Care (PHC) setting, you are approached by a pharmacist who has encountered a problem: the Ice Lined Refrigerator (ILR) malfunctioned, resulting in the freezing of the DPT (Diphtheria, Pertussis, Tetanus) vaccine. The pharmacist is seeking your advice on the appropriate course of action for the frozen vaccine. Handling such situations correctly is crucial to ensure vaccine safety and efficacy. What should be done with the DPT vaccine that has been frozen due to the ILR malfunction?",
      "options": [
        {
          "label": "A",
          "text": "Shaken thoroughly before use",
          "correct": false
        },
        {
          "label": "B",
          "text": "Brought to +2 to +8 degree temperature before use",
          "correct": false
        },
        {
          "label": "C",
          "text": "Discarded the vial",
          "correct": true
        },
        {
          "label": "D",
          "text": "Allowed to melt before use",
          "correct": false
        }
      ],
      "correct_answer": "C. Discarded the vial",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) Discarded the vial.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 DPT vaccine is sensitive to freezing , and freezing can alter its properties, making it ineffective or unsafe . The appropriate action is to discard any DPT vaccine that has been frozen.</li><li>\u2022 DPT vaccine</li><li>\u2022 sensitive</li><li>\u2022 freezing</li><li>\u2022 alter its properties,</li><li>\u2022 ineffective or unsafe</li><li>\u2022 discard any DPT vaccine</li><li>\u2022 been frozen.</li><li>\u2022 Shake test -</li><li>\u2022 Shake test -</li><li>\u2022 The Shake Test need not be conducted under the following circumstances - When solid frozen vaccine vial(s) have been found.</li><li>\u2022 Shake Test</li><li>\u2022 not</li><li>\u2022 solid frozen vaccine vial(s)</li><li>\u2022 Shake Test is used to assess the freeze damage to Aluminum based freeze sensitive vaccines such as DPT, TT, Td etc. If the sediments in the suspect vial settle more slowly , the suspect vaccine may be used.</li><li>\u2022 Shake Test</li><li>\u2022 freeze damage to Aluminum</li><li>\u2022 freeze sensitive vaccines</li><li>\u2022 DPT, TT, Td</li><li>\u2022 sediments</li><li>\u2022 suspect vial settle more slowly</li><li>\u2022 suspect vaccine</li><li>\u2022 used.</li><li>\u2022 The Shake Test currently applies to freeze sensitive vaccines which are:</li><li>\u2022 Shake Test</li><li>\u2022 freeze sensitive vaccines</li><li>\u2022 DPT-Hep B-Hib TT PCV13 Hepatitis B HPV</li><li>\u2022 DPT-Hep B-Hib</li><li>\u2022 TT</li><li>\u2022 PCV13</li><li>\u2022 Hepatitis B</li><li>\u2022 HPV</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Shake Test is used to assess the freeze damage to Aluminum based freeze sensitive vaccines such as DPT, TT, Td etc. If the sediments in the suspect vial settle more slowly , the suspect vaccine may be used</li><li>\u27a4 Shake Test</li><li>\u27a4 freeze damage</li><li>\u27a4 Aluminum based freeze</li><li>\u27a4 sensitive vaccines</li><li>\u27a4 DPT, TT, Td</li><li>\u27a4 sediments</li><li>\u27a4 suspect vial</li><li>\u27a4 settle more slowly</li><li>\u27a4 suspect vaccine</li><li>\u27a4 used</li><li>\u27a4 DPT vaccine is sensitive to freezing . The appropriate action is to discard any DPT vaccine that has been frozen.</li><li>\u27a4 DPT vaccine</li><li>\u27a4 sensitive to freezing</li><li>\u27a4 discard any</li><li>\u27a4 DPT vaccine</li><li>\u27a4 been frozen.</li><li>\u27a4 Ref: Park 27/e p123</li><li>\u27a4 Ref:</li><li>\u27a4 Park 27/e p123</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "77eee662",
      "audio": ""
    },
    {
      "text": "A nurse in a rural community health clinic is tasked with storing a new shipment of the Oral Polio Vaccine (OPV). She is aware that OPV requires specific storage conditions to maintain its efficacy, particularly in terms of temperature. In order to correctly store the OPV, she needs to ensure that the deep freezer is set to the appropriate temperature range. What is the correct temperature range that the nurse should maintain in the deep freezer for the optimal storage of the Oral Polio Vaccine?",
      "options": [
        {
          "label": "A",
          "text": "+ 2 degree C to + 8 degree C",
          "correct": false
        },
        {
          "label": "B",
          "text": "\u2013 2 degree C to \u2013 8 degree C",
          "correct": false
        },
        {
          "label": "C",
          "text": "\u2013 15 degree C to \u2013 25 degree C",
          "correct": true
        },
        {
          "label": "D",
          "text": "\u2013 8 degree C to \u2013 10 degree C",
          "correct": false
        }
      ],
      "correct_answer": "C. \u2013 15 degree C to \u2013 25 degree C",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-160928.jpg"
      ],
      "explanation": "<p><strong>Ans. C) \u2013 15 degree C to \u2013 25 degreeC</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 The cabinet temperature of the deep freezer is maintained between \u2013 15 degree C to \u2013 25 degree C .</li><li>\u2022 cabinet temperature</li><li>\u2022 deep freezer</li><li>\u2022 \u2013 15 degree C to \u2013 25 degree C</li><li>\u2022 Ice packs are prepared by keeping them in a Deep freezer.</li><li>\u2022 Ice packs</li><li>\u2022 Deep freezer.</li><li>\u2022 All vaccines are stored at a temperature of +2\u00b0 to +8\u00b0C including OPV (OPV vaccine is stored at -15\u00b0 to -25\u00b0C , i.e., Subzero/freezing temperatures only for long-term storage i.e. >1 month ) and YF vaccine is stored at -30\u00b0 to +5\u00b0C.</li><li>\u2022 All vaccines</li><li>\u2022 stored</li><li>\u2022 temperature</li><li>\u2022 +2\u00b0 to +8\u00b0C</li><li>\u2022 OPV</li><li>\u2022 stored</li><li>\u2022 -15\u00b0 to -25\u00b0C</li><li>\u2022 Subzero/freezing</li><li>\u2022 long-term storage</li><li>\u2022 >1 month</li><li>\u2022 YF vaccine</li><li>\u2022 -30\u00b0 to +5\u00b0C.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cold chain components (equipments) and levels in India:</li><li>\u27a4 Cold chain components (equipments) and levels in India:</li><li>\u27a4 Ref: Park 26 th ed pg118</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg118</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "372014e4",
      "audio": ""
    },
    {
      "text": "During an immunization logistics workshop, attendees, who include healthcare professionals and logistics coordinators, are learning about the cold chain system used for vaccine storage at different levels. One of the topics covered is the appropriate cold chain equipment for vaccine storage at the regional level. Knowing the correct type of equipment used at each level of the cold chain is crucial for maintaining vaccine efficacy. Which type of cold chain equipment is primarily used at the regional level to store vaccines?",
      "options": [
        {
          "label": "A",
          "text": "Walk in Freezer",
          "correct": true
        },
        {
          "label": "B",
          "text": "Large Deep freezer",
          "correct": false
        },
        {
          "label": "C",
          "text": "Ice line refrigerator",
          "correct": false
        },
        {
          "label": "D",
          "text": "Small Deep freezer",
          "correct": false
        }
      ],
      "correct_answer": "A. Walk in Freezer",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-160928_8DdLgqd.jpg"
      ],
      "explanation": "<p><strong>Ans. A) Walk in Freezer</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option B. Large Deep freezer : at district level , can store vaccine for 1 month, temperature is \u201315\u00b0C to \u201325\u00b0C</li><li>\u2022 Option B. Large Deep freezer</li><li>\u2022 district level</li><li>\u2022 1 month,</li><li>\u2022 \u201315\u00b0C to \u201325\u00b0C</li><li>\u2022 Option C. Ice line refrigerator ( ILR) : This is the most important component of the cold chain in India . Temperature of ILR (Cold chain) in India is +2\u00b0C to +8\u00b0C. ILR is used for storage of all vaccines . ILRs can maintain temperature of vaccines if provided with even 8 hours of uninterrupted electricity per day .</li><li>\u2022 Option C.</li><li>\u2022 Ice line refrigerator (</li><li>\u2022 ILR)</li><li>\u2022 cold chain</li><li>\u2022 India</li><li>\u2022 Temperature</li><li>\u2022 ILR (Cold chain)</li><li>\u2022 +2\u00b0C to +8\u00b0C.</li><li>\u2022 ILR</li><li>\u2022 storage</li><li>\u2022 all vaccines</li><li>\u2022 ILRs</li><li>\u2022 temperature of vaccines</li><li>\u2022 even 8 hours</li><li>\u2022 uninterrupted electricity per day</li><li>\u2022 Option D. Small Deep freezer : At PHC level, can store vaccine for 1 month, temperature is \u201315\u00b0C to \u201325\u00b0C</li><li>\u2022 Option D. Small Deep freezer</li><li>\u2022 PHC level,</li><li>\u2022 1 month,</li><li>\u2022 \u201315\u00b0C to \u201325\u00b0C</li><li>\u2022 Some important Pointers -</li><li>\u2022 Most important component of cold chain in India : ILR</li><li>\u2022 important</li><li>\u2022 component</li><li>\u2022 cold chain</li><li>\u2022 India</li><li>\u2022 ILR</li><li>\u2022 Minimum level of vaccine storage (in cold chain) in India: Primary health centre (below PHC level, vaccines are \u2018 transported to sub-centres on immunization days\u2019 in vaccine carriers and day carriers ).</li><li>\u2022 Minimum level</li><li>\u2022 Primary health centre</li><li>\u2022 transported to sub-centres</li><li>\u2022 immunization days\u2019</li><li>\u2022 vaccine carriers and day carriers</li><li>\u2022 Maximum chance of cold chain failure in India: Sub-centre and village level</li><li>\u2022 Maximum chance of cold chain</li><li>\u2022 failure</li><li>\u2022 Sub-centre and village level</li><li>\u2022 Instrument used to monitor the temperature of cold chain at PHC: Dial Thermometer.</li><li>\u2022 Instrument</li><li>\u2022 monitor</li><li>\u2022 temperature of cold chain</li><li>\u2022 Dial Thermometer.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cold chain components (equipments) and levels in India:</li><li>\u27a4 Cold chain components</li><li>\u27a4 levels in India:</li><li>\u27a4 Ref : Park 27th ed pg 118-120</li><li>\u27a4 Ref</li><li>\u27a4 : Park 27th ed pg 118-120</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ef9fc586",
      "audio": ""
    },
    {
      "text": "A community health worker is conducting a routine immunization camp in a rural village. During her visit, she encounters a mother with a 10-month-old boy who has not been vaccinated due to the family's constant relocations. The mother is now eager to start her child's vaccinations. Given the child's age and lack of prior immunizations, the community health worker needs to recommend a combination of vaccines for immediate administration to catch up with the standard immunization schedule. Which combination of vaccines should she recommend for the 10-month-old boy to protect him against preventable diseases?",
      "options": [
        {
          "label": "A",
          "text": "\u200b\u200b\u200b\u200b\u200bBCG, pentavalent, OPV, Rotavirus, PCV, IPV, MR, JE and Vitamin A",
          "correct": true
        },
        {
          "label": "B",
          "text": "BCG, Pentavalent, OPV, Rotavirus, PCV, IPV and after 4 weeks MR, JE, Vitamin A",
          "correct": false
        },
        {
          "label": "C",
          "text": "BCG, DPT, Hepatitis B, OPV, Rotavirus, PCV, IPV",
          "correct": false
        },
        {
          "label": "D",
          "text": "BCG, DPT, OPV, Rotavirus, PCV, IPV, MR, JE and Vitamin A",
          "correct": false
        }
      ],
      "correct_answer": "A. \u200b\u200b\u200b\u200b\u200bBCG, pentavalent, OPV, Rotavirus, PCV, IPV, MR, JE and Vitamin A",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-170954_LHU9k98.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-173401.jpg"
      ],
      "explanation": "<p><strong>Ans. A) BCG, pentavalent, OPV, Rotavirus, PCV, IPV, MR, JE and Vitamin A</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 It is safe and effective to give BCG, Penta, OPV, IPV, MR, RVV, PCV and JE (where applicable) vaccines and Vitamin A at the same time to a 9-month-old child who has never been vaccinated.</li><li>\u2022 safe and effective</li><li>\u2022 BCG, Penta, OPV, IPV, MR, RVV, PCV</li><li>\u2022 JE</li><li>\u2022 vaccines</li><li>\u2022 Vitamin A</li><li>\u2022 9-month-old</li><li>\u2022 never</li><li>\u2022 vaccinated.</li><li>\u2022 If more than one injection has to be given in one limb then ensure that the distance between the two injection sites is at least 1 inch apart.</li><li>\u2022 more</li><li>\u2022 one injection</li><li>\u2022 given</li><li>\u2022 one limb</li><li>\u2022 distance between</li><li>\u2022 two injection sites</li><li>\u2022 1 inch apart.</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Cases of delayed Immunization -</li><li>\u2022 Cases of delayed Immunization -</li><li>\u2022 Ref: Immunization handbook for health workers, 2018, MoHFW, GoI, pg 21; IAP Guidebook on Immunization</li><li>\u2022 Ref:</li><li>\u2022 Immunization handbook for health workers, 2018, MoHFW, GoI, pg 21; IAP Guidebook on Immunization</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "12e64a84",
      "audio": ""
    },
    {
      "text": "A 9-month-old child who has not received any immunizations is brought to a Primary Health Centre in India. As per the Universal Immunization Programme (UIP) schedule followed in India, it is essential to determine which vaccines the child should receive at this age to catch up with the national immunization schedule. For a 9-month-old infant who is unimmunized, which of the following vaccines should be administered according to the UIP schedule?",
      "options": [
        {
          "label": "A",
          "text": "MR1, JE1, IPV, PCV and Vitamin A",
          "correct": true
        },
        {
          "label": "B",
          "text": "MR1, JE1, PCV and Vitamin A",
          "correct": false
        },
        {
          "label": "C",
          "text": "MMR1, JE1, PCV and Vitamin A",
          "correct": false
        },
        {
          "label": "D",
          "text": "MR1, JE1, PCV, DPT Booster and Vitamin A",
          "correct": false
        }
      ],
      "correct_answer": "A. MR1, JE1, IPV, PCV and Vitamin A",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-173401_atjAruH.jpg"
      ],
      "explanation": "<p><strong>Ans. A) MR1, JE1, IPV, PCV and Vitamin A</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Vaccines to be given in situations of delayed immunizations in India \u2013 9 month old unimmunized child comes for immunization first time -</li><li>\u2022 Vaccines</li><li>\u2022 delayed immunizations in India</li><li>\u2022 9 month old unimmunized child</li><li>\u2022 immunization first time</li><li>\u2022 BCG (Direct) OPV1 (3 successive doses 1 month apart, booster after 1 year of 3rd dose) Pentavalent-1 /DPT1 (3 successive doses 1 month apart, booster after 1 year of 3rd dose) + HepB1 (3 successive doses 1 month apart) + HiB1 (2 successive doses 1 month apart) Measles-1/MR-1 Vitamin A (1 Lac IU) IPV-1 PCV-1 JE-1 Rota V-1</li><li>\u2022 BCG (Direct)</li><li>\u2022 OPV1 (3 successive doses 1 month apart, booster after 1 year of 3rd dose)</li><li>\u2022 Pentavalent-1 /DPT1 (3 successive doses 1 month apart, booster after 1 year of 3rd dose) + HepB1 (3 successive doses 1 month apart) + HiB1 (2 successive doses 1 month apart)</li><li>\u2022 Measles-1/MR-1</li><li>\u2022 Vitamin A (1 Lac IU)</li><li>\u2022 IPV-1</li><li>\u2022 PCV-1</li><li>\u2022 JE-1</li><li>\u2022 Rota V-1</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Cases of delayed immunization -</li><li>\u27a4 Ref: Park 26 th ed pg 135, NTAGI recommendations 2022</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed pg 135, NTAGI recommendations 2022</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "357803e9",
      "audio": ""
    },
    {
      "text": "In a pediatric review meeting, healthcare professionals are discussing various adverse reactions following vaccinations. A key point of discussion is the association of certain vaccines with thrombocytopenia, a condition characterized by an abnormally low number of platelets. One resident queries about a specific vaccine that has a known association with thrombocytopenia as a potential adverse reaction. Among the following, which vaccine is recognized for its linkage with thrombocytopenia?",
      "options": [
        {
          "label": "A",
          "text": "BCG",
          "correct": false
        },
        {
          "label": "B",
          "text": "JE",
          "correct": false
        },
        {
          "label": "C",
          "text": "MMR",
          "correct": true
        },
        {
          "label": "D",
          "text": "IPV",
          "correct": false
        }
      ],
      "correct_answer": "C. MMR",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-180930_PCGedPz.jpg"
      ],
      "explanation": "<p><strong>Ans. C) MMR</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. BCG : AEFI (rare)- Suppurative lymphadenitis, BCG osteitis, Disseminated BCGiosis</li><li>\u2022 Option A. BCG : AEFI (rare)-</li><li>\u2022 Option B. JE: AEFI - Enchephalitis, encephalopathy</li><li>\u2022 Option B. JE: AEFI -</li><li>\u2022 Option D. IPV : AEFI - Febrile convulsions</li><li>\u2022 Option D. IPV : AEFI -</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Vaccine and AEFI -</li><li>\u27a4 Vaccine and AEFI -</li><li>\u27a4 Ref: Park 27 th ed pg 245</li><li>\u27a4 Ref:</li><li>\u27a4 Park 27 th ed pg 245</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "f740c683",
      "audio": ""
    },
    {
      "text": "A 6-year-old child is brought to the emergency room after sustaining a scratch on her right hand while playing with a cat at home. The examination reveals a single scratch mark without any active bleeding. In such a scenario, determining the most appropriate medical intervention is crucial to prevent any potential complications. What should be the most appropriate intervention for this child at this time?",
      "options": [
        {
          "label": "A",
          "text": "Reassure the parents that there is no risk of rabies as it is a pet animal and give wound care",
          "correct": false
        },
        {
          "label": "B",
          "text": "Reassure the parents that there is no risk of rabies as it is a pet animal and give wound care",
          "correct": false
        },
        {
          "label": "C",
          "text": "Administer rabies immunoglobulin (RIG) along with wound care",
          "correct": false
        },
        {
          "label": "D",
          "text": "Administer rabies vaccine along with wound care",
          "correct": true
        }
      ],
      "correct_answer": "D. Administer rabies vaccine along with wound care",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2024/04/06/screenshot-2024-04-06-162956.jpg"
      ],
      "explanation": "<p><strong>Ans. D) Administer rabies vaccine along with wound care.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Category II situation - PEP is Immediate vaccination and Local treatment of wound</li><li>\u2022 Category II situation</li><li>\u2022 PEP</li><li>\u2022 Immediate vaccination</li><li>\u2022 Local treatment</li><li>\u2022 wound</li><li>\u2022 The components of post\u2013exposure prophylaxis are:</li><li>\u2022 components of post\u2013exposure prophylaxis</li><li>\u2022 Local treatment of wound Antibiotics and anti-tetanus measures Active immunization against rabies \u2013 if indicated Passive immunization with rabies immunoglobulin \u2013 if indicated Observe the animal for 10 days from the day of bite :</li><li>\u2022 Local treatment of wound</li><li>\u2022 Local treatment</li><li>\u2022 wound</li><li>\u2022 Antibiotics and anti-tetanus measures</li><li>\u2022 Antibiotics</li><li>\u2022 anti-tetanus measures</li><li>\u2022 Active immunization against rabies \u2013 if indicated</li><li>\u2022 Active immunization</li><li>\u2022 rabies</li><li>\u2022 Passive immunization with rabies immunoglobulin \u2013 if indicated</li><li>\u2022 Passive immunization</li><li>\u2022 rabies immunoglobulin</li><li>\u2022 Observe the animal for 10 days from the day of bite :</li><li>\u2022 animal for 10 days</li><li>\u2022 day of bite</li><li>\u2022 If healthy after 10 days : Discontinue post \u2013 exposure vaccination If dies within observation period : complete PEP If observation not possible: complete the post \u2013 exposure vaccination</li><li>\u2022 If healthy after 10 days : Discontinue post \u2013 exposure vaccination</li><li>\u2022 after 10 days</li><li>\u2022 post \u2013 exposure vaccination</li><li>\u2022 If dies within observation period : complete PEP</li><li>\u2022 dies</li><li>\u2022 observation period</li><li>\u2022 complete PEP</li><li>\u2022 If observation not possible: complete the post \u2013 exposure vaccination</li><li>\u2022 observation not</li><li>\u2022 complete</li><li>\u2022 post \u2013 exposure vaccination</li><li>\u2022 Local Treatment of Wound - Purpose of local treatment is to remove as much virus as possible, from site of inoculation, before it is absorbed on local nerve endings . Local wound treatment can reduce chances of Rabies by upto 80%.</li><li>\u2022 Local Treatment of Wound</li><li>\u2022 Purpose</li><li>\u2022 remove</li><li>\u2022 virus</li><li>\u2022 site of inoculation, before</li><li>\u2022 absorbed on local nerve endings</li><li>\u2022 Local wound treatment</li><li>\u2022 reduce</li><li>\u2022 Rabies</li><li>\u2022 upto 80%.</li><li>\u2022 Immediate flushing and washing wound area with plenty of soap and running water for minimum 15 minutes. Suturing: not recommended ; if necessary, do 24\u201348 hours later under cover of Anti-rabies serum (Local application with prior sensitivity testing) Chemical treatment with virucidal agents ( Alcohol, tincture, 0.01% aqueous iodine )</li><li>\u2022 Immediate flushing and washing wound area with plenty of soap and running water for minimum 15 minutes.</li><li>\u2022 Immediate flushing</li><li>\u2022 washing wound area</li><li>\u2022 plenty of soap</li><li>\u2022 running water</li><li>\u2022 minimum 15 minutes.</li><li>\u2022 Suturing: not recommended ; if necessary, do 24\u201348 hours later under cover of Anti-rabies serum (Local application with prior sensitivity testing)</li><li>\u2022 Suturing: not recommended</li><li>\u2022 24\u201348 hours later</li><li>\u2022 cover</li><li>\u2022 Anti-rabies serum</li><li>\u2022 Chemical treatment with virucidal agents ( Alcohol, tincture, 0.01% aqueous iodine )</li><li>\u2022 Chemical treatment</li><li>\u2022 virucidal agents</li><li>\u2022 Alcohol, tincture, 0.01% aqueous iodine</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective:</li><li>\u27a4 Ref: Park 26 th ed 324</li><li>\u27a4 Ref:</li><li>\u27a4 Park 26 th ed 324</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "b1943ffe",
      "audio": ""
    },
    {
      "text": "In a prenatal consultation, a pregnant woman expresses concerns about the safety of receiving vaccinations during her pregnancy. It's crucial for healthcare providers to be aware of which vaccines are safe and which are contraindicated during pregnancy to ensure the health of both the mother and the developing fetus. The woman asks about specific vaccines and their safety in pregnancy. Which of the following vaccines is CONTRAINDICATED for pregnant women?",
      "options": [
        {
          "label": "A",
          "text": "Rabies vaccine",
          "correct": false
        },
        {
          "label": "B",
          "text": "Hepatitis B vaccine",
          "correct": false
        },
        {
          "label": "C",
          "text": "MR vaccine",
          "correct": true
        },
        {
          "label": "D",
          "text": "Tetanus toxoid",
          "correct": false
        }
      ],
      "correct_answer": "C. MR vaccine",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. C) MR vaccine</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Option A. Rabies, Option B. Hep B and Option D. TT - can be given during Pregnancy .</li><li>\u2022 Option A. Rabies, Option B. Hep B and Option D. TT</li><li>\u2022 given</li><li>\u2022 Pregnancy .</li><li>\u2022 Educational objective:</li><li>\u2022 Educational objective:</li><li>\u2022 Vaccines contraindicated in Pregnancy - All live vaccines except Yellow fever vaccine.</li><li>\u2022 Vaccines contraindicated</li><li>\u2022 Pregnancy</li><li>\u2022 except Yellow fever vaccine.</li><li>\u2022 Ref: Park 27 th ed. Pg 111</li><li>\u2022 Ref:</li><li>\u2022 Park 27 th ed. Pg 111</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "a2b595d4",
      "audio": ""
    },
    {
      "text": "Simplest measure of estimating burden of a disease in the community is?",
      "options": [
        {
          "label": "A",
          "text": "Disease specific mortality rate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Proportional mortality rate",
          "correct": true
        },
        {
          "label": "C",
          "text": "DALY",
          "correct": false
        },
        {
          "label": "D",
          "text": "Years of Potential life lost",
          "correct": false
        }
      ],
      "correct_answer": "B. Proportional mortality rate",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/08/23/screenshot-2023-08-11-1921039022.jpg"
      ],
      "explanation": "<p><strong>Ans. B. Proportional mortality rate.</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 Option A. Disease specific mortality rate : It is the number of deaths occurring in a community due to a specific disease in a given period of time.</li><li>\u2022 Option A.</li><li>\u2022 Disease specific mortality rate</li><li>\u2022 number of deaths</li><li>\u2022 community</li><li>\u2022 Option C. DALY is disability-adjusted life years , which is the best measure of disease burden , including both reduction in life expectancy and diminished quality of life. It can measure both mortality and disability together.</li><li>\u2022 Option C.</li><li>\u2022 DALY</li><li>\u2022 disability-adjusted life years</li><li>\u2022 best measure of disease burden</li><li>\u2022 DALY = YLL (years of life lost) + YLD (years lost to disability)</li><li>\u2022 Option D. Years of Potential Life Lost : It is based on the years of life lost through premature death. It is a type of mortality indicator.</li><li>\u2022 Option D.</li><li>\u2022 Years of Potential Life Lost</li><li>\u2022 years of life lost</li><li>\u2022 premature death.</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Ref : Park 26 th ed, pg 25.</li><li>\u27a4 Ref : Park 26 th ed, pg 25.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "ef637885",
      "audio": ""
    },
    {
      "text": "Which of the following index refers to Sullivan\u2019s index?",
      "options": [
        {
          "label": "A",
          "text": "\u200b\u200b\u200b\u200b\u200b Life expectancy at birth",
          "correct": false
        },
        {
          "label": "B",
          "text": "Disability free life expectancy",
          "correct": true
        },
        {
          "label": "C",
          "text": "Average life expectancy",
          "correct": false
        },
        {
          "label": "D",
          "text": "Expectation of life at 1 year of age",
          "correct": false
        }
      ],
      "correct_answer": "B. Disability free life expectancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Disability free life expectancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Sullivan\u2019s indicator is a health state measure of a group of persons which is independent of its age structure.</li><li>\u2022 Sullivan\u2019s indicator</li><li>\u2022 health state measure</li><li>\u2022 group of persons</li><li>\u2022 independent</li><li>\u2022 age structure.</li><li>\u2022 Sullivan\u2019s Index , now called DFLE (Disability-free life expectancy), means the average number of years an individual is expected to live free of disability (given the current mortality and disability). It is calculated as Life expectancy minus duration of disability</li><li>\u2022 Sullivan\u2019s Index</li><li>\u2022 DFLE</li><li>\u2022 average number of years</li><li>\u2022 individual is expected to live free</li><li>\u2022 disability</li><li>\u2022 calculated as Life expectancy minus duration of disability</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 DFLE = Sullivan's Index</li><li>\u27a4 Ref : Textbook of Community medicine, AH Suryakantha, 4 th ed, pg10.</li><li>\u27a4 Ref</li><li>\u27a4 : Textbook of Community medicine, AH Suryakantha, 4 th ed, pg10.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4abed2cb",
      "audio": ""
    },
    {
      "text": "Dr. Kapoor, a public health expert in Delhi, is giving a lecture on different health indicators. He discusses various metrics used to gauge the health of a population. Which of the following metrics presented by him is specifically considered a Mortality Indicator?",
      "options": [
        {
          "label": "A",
          "text": "Notification Rate",
          "correct": false
        },
        {
          "label": "B",
          "text": "Life expectancy",
          "correct": true
        },
        {
          "label": "C",
          "text": "DALY",
          "correct": false
        },
        {
          "label": "D",
          "text": "Bed turnover ratio",
          "correct": false
        }
      ],
      "correct_answer": "B. Life expectancy",
      "question_images": [],
      "explanation_images": [],
      "explanation": "<p><strong>Ans. B. Life expectancy</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation :</li><li>\u2022 Option A . Notification Rate is related to the number of cases of a particular disease that are reported in a specific time period.</li><li>\u2022 Option A</li><li>\u2022 Notification Rate</li><li>\u2022 number of cases</li><li>\u2022 particular disease</li><li>\u2022 Option C . DALY : Disability-Adjusted Life Years is a composite measure that combines information on premature mortality (years of life lost due to premature death) and morbidity (years lived with disability).</li><li>\u2022 Option C</li><li>\u2022 DALY</li><li>\u2022 Disability-Adjusted Life Years</li><li>\u2022 composite measure</li><li>\u2022 combines information</li><li>\u2022 premature mortality</li><li>\u2022 morbidity</li><li>\u2022 Option D . Bed turn-over ratio is a measure of hospital efficiency and represents the number of times a hospital bed gets occupied in a specific time frame.</li><li>\u2022 Option D</li><li>\u2022 Bed turn-over ratio</li><li>\u2022 measure of hospital efficiency</li><li>\u2022 number of times</li><li>\u2022 hospital bed gets occupied</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective :</li><li>\u27a4 Life Expectancy is a direct Mortality Indicator , contrasting with Notification's disease report focus , DALY's is a type of disability rate , and Bed turn-over's hospital efficiency metric / health care utilization rate .</li><li>\u27a4 Life Expectancy</li><li>\u27a4 direct Mortality Indicator</li><li>\u27a4 Notification's disease report focus</li><li>\u27a4 DALY's</li><li>\u27a4 type of disability rate</li><li>\u27a4 Bed turn-over's hospital efficiency metric</li><li>\u27a4 health care utilization rate</li><li>\u27a4 Ref : Park 26 th ed, pg25</li><li>\u27a4 Ref : Park 26 th ed, pg25</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "c48d2712",
      "audio": ""
    },
    {
      "text": "A 45-year-old man is living in an area where there has been a recent outbreak of a contagious viral disease. The disease agent has not yet entered his body, but all the environmental conditions and factors favoring interaction between the host and the agent are present. He is currently healthy and does not exhibit any symptoms of the disease. Based on this scenario, in which stage of the natural history of disease is this man currently situated?",
      "options": [
        {
          "label": "A",
          "text": "Pathogenesis phase",
          "correct": false
        },
        {
          "label": "B",
          "text": "Pre pathogenesis phase",
          "correct": true
        },
        {
          "label": "C",
          "text": "Pre symptomatic phase",
          "correct": false
        },
        {
          "label": "D",
          "text": "Latent phase",
          "correct": false
        }
      ],
      "correct_answer": "B. Pre pathogenesis phase",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/07/07/image-20230707160024-1.png"
      ],
      "explanation": "<p><strong>Ans. B. Pre pathogenesis phase</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation:</li><li>\u2022 Natural history of disease \u2013 This refers to the progression of a disease in an individual over time , in the absence of treatment . It has two phases, a period of prepathogenesis and a period of pathogenesis.</li><li>\u2022 Natural history of disease</li><li>\u2022 progression of a disease</li><li>\u2022 individual over time</li><li>\u2022 absence of treatment</li><li>\u2022 1. Pre pathogenesis phase - This refers to the period preliminary to the onset of disease in man . The disease agent has not yet entered man, but the factors which favor its interaction with the human host are already existing in the environment . It is the period of susceptibility.</li><li>\u2022 Pre pathogenesis phase</li><li>\u2022 period preliminary to the onset of disease in man</li><li>\u2022 .</li><li>\u2022 2 . Pathogenesis phase - It begins with the entry of the disease \"agent\" in the susceptible human host . Progress through period of incubation and later through early and late pathogenesis. Pathogenesis may be modified by interventions such as immunization and chemotherapy.</li><li>\u2022 . Pathogenesis phase</li><li>\u2022 begins with the entry of the disease \"agent\" in the susceptible human host</li><li>\u2022 Rehabilitation has been defined as the use of medical, social, educational, and vocational measures for training the individual to the highest possible level of functional ability</li><li>\u2022 Rehabilitation</li><li>\u2022 use of medical, social, educational, and vocational measures</li><li>\u2022 training the individual</li></ul>\n<p><strong>Educational Objective:</strong></p><ul><li>\u27a4 Educational Objective</li><li>\u27a4 :</li><li>\u27a4 Ref : Park 26 th ed pg 42.</li><li>\u27a4 Ref : Park 26 th ed pg 42.</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "4ac9e642",
      "audio": ""
    },
    {
      "text": "The maximum and minimum value for life expectancy in HDI ranges between?",
      "options": [
        {
          "label": "A",
          "text": "20 to 85 years",
          "correct": true
        },
        {
          "label": "B",
          "text": "20.2 to 70.6 years",
          "correct": false
        },
        {
          "label": "C",
          "text": "20 to 83.2 years",
          "correct": false
        },
        {
          "label": "D",
          "text": "20.6 to 80.2 years",
          "correct": false
        }
      ],
      "correct_answer": "A. 20 to 85 years",
      "question_images": [],
      "explanation_images": [
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/08/screenshot-2023-12-08-103926.jpg",
        "https://cerebellum-web-static.s3.amazonaws.com/media/public/images/2023/12/08/screenshot-2023-12-08-103040.jpg"
      ],
      "explanation": "<p><strong>Ans. A. 20 to 85 years</strong></p>\n<p><strong>Explanation:</strong></p><ul><li>\u2022 Explanation</li><li>\u2022 :</li><li>\u2022 HDI \u2013 Human Development Index</li><li>\u2022 HDI</li><li>\u2022 Human Development Index</li><li>\u2022 It is a composite index used to assess the health status and development of a country .</li><li>\u2022 composite index</li><li>\u2022 assess the health status</li><li>\u2022 development of a country</li><li>\u2022 Life Expectancy at Birth Education (Mean years of schooling and Completed & Expected Years of Schooling) Standard of Living (Per capita income/Purchasing power parity)\u200b\u200b\u200b\u200b\u200b\u200b            \u200b\u200b\u200b\u200b</li><li>\u2022 Life Expectancy at Birth</li><li>\u2022 Life Expectancy</li><li>\u2022 Birth</li><li>\u2022 Education (Mean years of schooling and Completed & Expected Years of Schooling)</li><li>\u2022 Education</li><li>\u2022 Standard of Living (Per capita income/Purchasing power parity)\u200b\u200b\u200b\u200b\u200b\u200b            \u200b\u200b\u200b\u200b</li><li>\u2022 Standard of Living</li><li>\u2022 HDI index as per New Guidelines for calculation, 2018 -</li><li>\u2022 Calculation of each dimension index:</li><li>\u2022 Calculation of each dimension index:</li><li>\u2022 Calculation of each dimension index:</li><li>\u2022 HDI is Geometric mean of 3-dimension indices \u2013 I life 1/3 x I Education 1/3 x I Income 1/3 HDI values range: 0 to + 1 HDI India is 0.633 (Rank 132 out of 189 countries) [2022] Human poverty index [HPI] is complementary to HDI.</li><li>\u2022 HDI is Geometric mean of 3-dimension indices \u2013 I life 1/3 x I Education 1/3 x I Income 1/3</li><li>\u2022 HDI values range: 0 to + 1</li><li>\u2022 HDI India is 0.633 (Rank 132 out of 189 countries) [2022]</li><li>\u2022 Human poverty index [HPI] is complementary to HDI.</li><li>\u2022 Ref : Park 26th ed, pg 18</li><li>\u2022 Ref : Park 26th ed, pg 18</li></ul>\n<p></p>",
      "bot": "@dams_new_robot",
      "video": "",
      "uid": "35943ace",
      "audio": ""
    }
  ]
}